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Abstract
EXPLORING THE MECHANISM OF ALGINATE ACETYLATION IN PSEUDOMONAS
AERUGINOSA
Janice Lynne Paletta
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2010

Major Director: Dennis E. Ohman, Ph.D.
Chairman, Department of Microbiology and Immunology

The opportunistic pathogen P. aeruginosa is the leading cause of morbidity and mortality
in cystic fibrosis patients. During chronic infection of the cystic fibrosis lung, P. aeruginosa
undergoes conversion to a mucoid phenotype, constitutively producing the exopolysaccharide
alginate, composed of the uronic acids -D-mannuronate and -L-guluronate. This alginate
production contributes significantly to virulence in the cystic fibrosis lung. Evidence suggests
that the acetylation state of the mannuronate component of the alginate influences the ability of
components of the immune system to phagocytose the organism. To garner new and relevant
information regarding the mechanism of alginate acetylation in Pseudomonas aeruginosa, a
variety of approaches were undertaken. Analysis of the alginate produced by algX, algG, and
algK alginate biosynthesis mutants revealed that the small oligouronides they produced were
unacetylated. This strongly supports the hypothesis that the mannuronates are acetylated in
periplasm, and that a polymer of at least some specific size is required.

xi

While three alginate biosynthesis gene products (AlgI, AlgJ, and AlgF) have been shown
to be involved in alginate acetylation, another gene in the cluster, algX, shares 30% identity with
one of them and thus generates speculation as to its potential involvement in the process. To test
this possibility, an algX mutant was complemented with a plasmid carrying a mutation at a
conserved residue shown to be required for alginate acetylation in the homologous protein.
Analysis of alginate from this construct suggested that AlgX is not involved in alginate
acetylation.
To determine if changes in levels of alginate acetylation are accomplished at the
transcriptional level, transcript levels of several alginate biosynthesis genes in different media
were determined by real-time PCR. As qRT-PCR had not been previously performed on any of
the alginate biosynthesis genes, this yielded important information about the transcription of the
operon. In addition, beta-galactosidase assays on upstream regions of several biosynthesis genes
identified two previously unrecognized promoters, one upstream of algG and one upstream of
algI.
The remaining approach was to examine protein interactions of AlgF, the protein product
of one of the three acetylation genes. 2-D redox SDS-PAGE gels indicated that disulfide
bonding may be important for interactions with this protein. While mass spectrometry was
unable to identify the binding partners of AlgF, efforts are ongoing to create a mutation in the P.
aeruginosa genome that changes the cysteine residue in AlgF to a serine residue. This would be
a definitive method for determining the importance of disulfide bonding in AlgF.
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Introduction

The genus Pseudomonas
The genus Pseudomonas includes a diverse array of species covering a very broad host
range. In addition to many innocuous soil and water species, members of the genus
Pseudomonas include agricultural pathogens such as P. syringae, which causes bacterial speck in
tomatoes, and P. tolaasii, the causative agent of brown blotch disease in mushrooms, as well as
the opportunistic human pathogen, P. aeruginosa. This gram-negative bacterium is able to cause
a myriad of infections in a human host, including folliculitus, corneal ulcers, endocarditis and
bacteremia [1]. One of the most devastating infections, caused by P. aeruginosa strains
constitutively producing the mucoid exopolysaccharide alginate, occurs in the lungs of
immunocompromised patients or those individuals suffering from the genetic disease cystic
fibrosis. Members of this genus are capable of surviving in very diverse environments, from oil
spills to the human lung, in part because of their ability to metabolize a wide variety of
substances to fulfill their nutritional requirements. Some species of Pseudomonas carrying
degradative plasmids are capable of metabolizing hydrocarbons and other toxic organic
compounds for survival and are often targeted by industry for commercial usage [2]. Another
key factor that contributes to the ability of members of this genus to survive is their natural
resistance to antibiotics. P. aeruginosa strains possess multiple means of resistance such as
plasmid-encoded -lactamases, enzymes that modify aminoglycosides by acetylation or
adenylation, multidrug efflux pumps and regulation of outer membrane porins [3] [1]. This
natural antibiotic resistance works in concert with other virulence factors, such as proteases,
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hemolysins, alginate, pili, and toxins to make P. aeruginosa an important human pathogen and
an organism of great clinical and research significance.

P. aeruginosa and the cystic fibrosis lung
As mentioned previously, one of the most devastating infections caused by P.
aeruginosa is the chronic lung infection of cystic fibrosis patients with a mucoid strain of the
bacterium. Cystic fibrosis is a genetic disease that results from mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, the gene product of which is a chloride
channel present in epithelial cells found in the tissues of the intestine, pancreas, sweat ducts, and
lungs [4]. A consequence of the malfunctioning chloride channel is the production of
abnormally thick mucous secretions that can block organ passages and cause nutritional
deficiencies, breathing complications and lung damage. The uncleared mucus in the lungs
contributes to an environment that is conducive to the growth of various bacterial species.
Haemophilus influenzae, Staphylococcus aureus, and P. aeruginosa can all thrive in this
environment and typically colonize patients with cystic fibrosis [4]. Non-mucoid strains of P.
aeruginosa will colonize the lung early in the lives of cystic fibrosis patients; however, the
conversion to a mucoid strain often signals the rapid and severe deterioration of pulmonary
function. Mucoid conversion of P. aeruginosa is often due to mutations in the mucA gene,
encoding an anti-sigma factor, that cause the constitutive transcription of the alginate
biosynthesis operon [5]. This conversion results in the excretion of alginate and is accompanied
by the coordinate regulation of other genes such as the down regulation of flagellar genes and the
loss of the LPS O-side chain aiding in the bacteria’s survival within the lung environment [6] [7].
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Alginate biosynthesis operon
The production of alginate in P. aeruginosa is due to the expression of the algD operon
and the algC gene, located outside of the algD operon and dually involved in lipopolysaccharide
biosynthesis [8]. The algD operon consists of 12 genes encoding proteins with putative
structural and enzymatic functions responsible for the generation of acetylated alginate polymer
(Figure 1 A. and B.). Current evidence supports the following proposed roles for the alginate
biosynthesis proteins: AlgD - GDP-mannose dehydrogenase [9], Alg8 – glycosyltransferase
[10], Alg44 – polymerization [11], AlgK – scaffold [12], AlgE – outer membrane porin [13],
AlgG – epimerase [14], AlgX – scaffold [15], AlgL – alginate lyase [16], AlgI – acetylation
[17], AlgJ – acetylation [17], AlgF – acetylation [18], and AlgA – phosphomannose isomerase
and GDP-mannose pyrophosphorylase [19, 20]. The algC gene encodes a phosphomannomutase
[8].
Many genetic studies have provided valuable information regarding how the alginate
polymer is synthesized and exported, however, there are still aspects of the process for which the
mechanism is unclear. Genetic and metabolic studies have shown that the algD, algC, and algA
gene products are all required to ultimately form GDP-mannuronate, the uronic acid precursor
needed for the formation of the alginate polymer [8] [20] [21]. Mutation of the alg8 gene, an in
vitro assay, and structural similarities all indicate that alg8 encodes a glycosyltransferase and is
responsible for polymerization [22-24]. Insertional mutation of alg44 has shown that the alg44
gene product is also required for alginate polymerization and likely functions along with Alg8 in
polymerization and transport of the sugar across the inner membrane [25]. Deletion of the algI,
algJ, or algF gene results in the production of a non-acetylated alginate polymer indicating that
all of these genes are required for the acetylation of alginate [17, 18]. It is unclear, however,
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how the exact mechanism of acetylation occurs. Both genetic and enzymatic studies have shown
that the algG gene product is a C5-mannuronan epimerase [26], and demonstrated lyase activity
from expression of the P. aeruginosa algL gene product in E. coli supports the role of AlgL as an
alginate lyase [16]. Both of these genes are believed to function in dual roles as the deletion of
the algG, algL, algX, or algK gene results in the secretion of small uronic acid fragments,
demonstrated to be products of AlgL degradation [15, 27]. This suggests that a periplasmic
scaffold complex composed of AlgG, AlgL, AlgX and AlgK may be required for successful
polymerization and secretion of alginate and that in the absence of any of these scaffold proteins
the alginate polymer can be accessed and degraded by the alginate lyase [27]. Finally, genetic
and immunologic studies have demonstrated that algE encodes an outer membrane porin through
which the alginate polymer is secreted [13, 28].
Alginate biosynthesis gene expression is regulated by AlgT, AlgR, AlgB and AmrZ.
Environmental signals such as high osmolarity, starvation and oxygen availability have been
shown to influence alginate production, however, the exact manner by which each of these
signals leads to an increase in alginate production still requires investigation [29].
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Figure 1. Model for polymerization, transport and acetylation of alginate in P. aeruginosa
and schematic representation of alginate biosynthesis operon. A. Alg8 and Alg44 form a
polymerase complex while AlgG, AlgX, AlgL, and AlgK form a hypothetical scaffold complex
for the transport of alginate through the periplasm to AlgE, an outer membrane secretin. AlgI,
AlgJ and AlgF are responsible for acetylation of the alginate polymer. Black circles represent
acetyl groups; grey hexagons represent mannuronates and guluronates. B. Schematic
representation of twelve gene operon responsible for alginate production showing gene order,
intergenic spaces, and the PalgD promoter.
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Regulation of alginate biosynthesis in Pseudomonas aeruginosa
Regulation of alginate production in P. aeruginosa is a multi-layered process, some
aspects of which are not yet fully understood. The promoter for the alginate biosynthesis
operon, PalgD, consists of an approximately one kilobase region upstream of the algD coding
region, and is regulated by a sigma 22 factor, AlgT [30]. This sigma factor is also referred to as
AlgU, sigma 22, and RpoE [31]. In non-mucoid strains of P. aeruginosa, AlgT is sequestered in
the cytoplasm by the anti-sigma factor MucA, preventing activation of PalgD and subsequent
transcription of alginate biosynthesis genes [30]. Mutations in mucA can impair the ability of
MucA to bind AlgT and results in unregulated production of alginate. One study determined that
84% of mucoid P. aeruginosa isolates from cystic fibrosis patients had a mutation in the mucA
gene [32]. Unregulated alginate production can also result from a mutation in mucB, causing
constitutive activation of the operon [33]. The MucB protein is believed to be localized to the
periplasm and may be part of a signal transduction complex which acts through MucA to control
activity of AlgT [34].
In addition to AlgT, transcription from PalgD requires two response regulators, AlgR and
AlgB, and an activator, AmrZ [35] [36] [32]. It has been demonstrated that transcription of algR,
algB and amrZ are all dependent upon AlgT [37, 38]. The alginate biosynthesis gene algC,
while expressed independently of the other biosynthesis genes, is also subject to regulation by
AlgR [39].
It is possible that under certain conditions a sigma factor besides AlgT may be involved
in alginate regulation. A potential sigma 54 (RpoN) binding site was identified in the upstream
regions of algD and algR and fusions of those promoter regions to a reporter showed a decrease
in transcription in a sigma 54 mutant strain compared to wild type [40]. Additionally, sigma 54
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was shown to be necessary for alginate production in a mucoid strain with mutations in unknown
genes, designated muc23 [41]. This same work highlights the possibility that there may be some
level of competition between AlgT and sigma 54 due to the overlap of promoter consensus
sequences.

Regulation of alginate biosynthesis in Azotobacter vinelandii
Regulation of alginate biosynthesis in A. vinelandii is somewhat different than in P.
aeruginosa. Unlike the alginate biosynthesis operon in Pseudomonas that appears to be
organized into just one transcriptional unit driven by PalgD, the alginate biosynthesis operon of A.
vinelandii is organized into four transcriptional units. One includes algD with transcription
being driven from two promoters. Promoter P1 is a sigma D type promoter, while P2 is a sigma E
type promoter similar to AlgT [42]. A sigma S type promoter (involved in the general stress
response) has been shown to drive transcription of alg8, alg44, algK and algE as a second
transcriptional unit [43]. The third operon within the biosynthetic gene cluster includes genes
algG through algF and sequence at the -10 and -35 regions upstream of the mRNA start site do
not correspond to any known promoter consensus sequences. They do, however, share similarity
to the -10 and -35 regions of the algR promoter region [44]. The final transcriptional unit is
composed only of algA, but the promoter has not been characterized. It was demonstrated that
transcription from this promoter alone was insufficient to generate a mucoid phenotype [44].
The differences in alginate regulation between A. vinelandii and P. aeruginosa may be
due in part to the ability of A. vinelandii to form metabolically dormant cysts during its lifecycle,
of which alginate is a major component [45].
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Alginate acetylation and opsonization
The alginate produced by mucoid strains of P. aeruginosa is a linear copolymer
composed of the uronic acids -D-mannuronate and its C-5 epimer -L-guluronate [46]. Uronic
acids differ from their parent sugars by the oxidation of the alcohol group (CH2OH) to a carboxyl
group (COOH). The alginate produced by P. aeruginosa contains repeating units of
mannuronate interspersed with guluronate, but does not contain repeating blocks of guluronate.
Since the guluronic acid readily binds Ca2+, which stabilizes the structure, the amount of
guluronate in the polymer affects physical properties such as viscosity [10]. Another factor that
can affect the properties of the alginate is the acetylation of the oxygen at the C-2 and C-3
positions of the mannuronate (Figure 2). Acetylation increases the hydration of the polymer and
has been shown to affect the sequence of guluronate and mannuronate units [46]. In a biological
system, the alginate secreted by P. aeruginosa is a potent virulence factor that has been shown to
block immunologic epitopes to inhibit antibody binding [47], inhibit the chemotaxis of
neutrophils [48], prevent the diffusion of some antibiotics [49], and scavenge free radicals [50].

11

Figure 2. Structure of uronic acid components showing acetylated mannuronate.
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Research Objectives
While the importance of the role played by alginate acetylation in virulence is clear, the
exact mechanism of how the polymer is acetylated is still undetermined. It is not known if all of
the proteins important in alginate acetylation have been identified, as it is likely that there may
be interacting proteins that originate outside of the alginate biosynthesis operon (as in AlgC). In
spite of the large volume of data available on regulation in P. aeruginosa from the algD
promoter, there has been little work done regarding transcription or regulation within the gene
cluster [13, 51]. In an attempt to broaden the current knowledge in these areas, this work focuses
on the following three objectives:
1) Characterize the alginate acetylation of available alginate biosynthesis mutants.
While in most cases alginate production by mutant strains has been characterized,
acetylation has not been studied to the same extent. Additional information may be
obtained by studying acetylation in conjunction with uronic acid production.
2) Identify other proteins involved in acetylation. This includes examining a possible
role for algX, as well as isolating any proteins that may interact with AlgF.
3) Perform transcriptional analysis on genes within the alginate biosynthesis operon,
especially those that may affect acetylation. Quantitative real-time PCR has not been
performed on genes within the operon and any information gathered would be
beneficial. Results of the qRT-PCR can provide direction for additional
transcriptional or translational studies.
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Materials and Methods

Media and bacterial growth conditions
Pseudomonas was typically cultured in Luria-Bertani liquid media at 37°C with shaking.
For maintenance of ampicillin-resistance plasmids in P. aeruginosa, carbenicillin at 150 µg/ml
was added to the media. In some cases, a Modified Alginate Promoting media consisting of
0.017 M K2HPO4, 7.5 mM NaH2PO4, 0.02 M MgSO4, 0.12 M L-glutamate, and 0.1 M Dgluconate was used for P. aeruginosa culture. MacConkey media (Difco™) and Pseudomonas
Isolation Agar (Difco™) were reconstituted with water per the manufacturer’s instructions.
E. coli was also typically cultured in Luria Bertani liquid media at 37°C with shaking.
Where necessary, antibiotics were added at the following concentrations: ampicillin – 100
µg/ml, kanamycin – 30 µg/ml, and gentamycin – 15 µg/ml.
Growth on solid media for both bacteria was typically carried out on Luria-Bertani agar
plates with addition of antibiotics at the concentrations stated above where required.
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Table 1. Description of bacterial strains
Strains

Genotype and/or Phenotype*

Source

P. aeruginosa
FRD1
FRD1100
FRD1108
FRD1144
FRD1175
FRD1200
FRD2
FRD462
JLP4
JLP98
JLP113
JLP121
JLP135
JLP162
JLP173
JLP179
JLP182
JLP184
JLP196

Prototrophic, mucA22, mucoid
r
FRD1algK::Gm
r
FRD1alg8::Gm
r
FRD1alg44::Gm
FRD1ΔalgF, mucoid
r
FRD1algG::Gm , non-mucoid
FRD1 revertant, non-mucoid
FRD1algG4, mucoid
r
FRD1algX::Gm , non-mucoid
FRD1 with pJP11, mucoid
FRD1175 with pJP11, mucoid
r
FRD1algX::Gm , pJP12, mucoid
r
r
FRD1algX::Gm , pJP14, Cb , mucoid
r
pJP20, Cb
r
pJP16, Cb
r
pJP18, Cb
r
pJP19, Cb
r
pJP17, Cb
pLW149a

Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
Ohman lab strain
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

JLP102
JLP3
JLP54
JLP106
JLP131
JLP149
JLP159
JLP170
JLP167
JLP165
JLP162
LW1569
JLP30
JLP33
JLP32
JLP35
JLP43
JLP65
JLP150
JLP148
JLP153

pJP12
r
Kan , pRK2013
r
pUC19, Ap
r
pJP13, Ap
r
pJP14, Ap
r
pSS269, Ap
pSS269, pJP16
pSS269, pJP17
pSS269, pJP18
pSS269, pJP19
pSS269, pJP20
pSS269, pLW149a
pASK-IBA63b-plus
pSS125
pSS124
pJP2
pJP5
pJP11
pJP21
pEX18Ap
pJP22

This study
Ohman lab strain
Ohman lab strain
This study
This study
Ohman lab strain
This study
This study
This study
This study
This study
Ohman lab strain
IBA GmbH
Ohman lab strain
Ohman lab strain
This study
This study
This study
This study
Ohman lab strain
This study

E. coli

r

r

r

r

*Abbreviations: Ap , ampicillin resistance; Cb , carbenicllin resistance; Gm , gentamicin resistance; Kan , kanamicin
resistance
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Table 2. Description of bacterial plasmids
Plasmids
pASK-IBA63b
pEX18Ap
pJP2
pJP5
pJP11
pJP12
pJP13
pJP14
pJP16
pJP17
pJP18
pJP19
pJP20
pJP21
pJP22
pLW149a
pMF54
pRK2013
pSS124
pSS125
pSS269
pUC19
r

Genotype*
r

Ptet >Strep-II tag, Ap , Tet-repressor
r
s
lacZα, oriT, Ap , Suc
pASK-IBA63b-plus with oriT
pJP2 with mSF
pJP5 with algF
pMF54 with algX
pUC19 with algX H176A
pMF54 with algX H176A
pSS269 with algG upstream
pSS269 with algX upstream
pSS269 with algJ upstream
pSS269 with algF upstream
pSS269 with algI upstream
pUC19 with algF C194S
pEX18Ap with algF C194S
pSS269 with algD upstream
r
q
Ptrc, Ap , oriT, SF, lacI
+
r
ColE1-Tra(RK2) , Kan
pUC1819 with mSF
pUC1819 with oriT
r
trp-lacZ1, mSF, oriT, Ap
r
Ap
r

Source
IBA GmbH
[52]
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Ohman lab construct
Ohman lab construct
[53]
[54]
[54]
Ohman lab contruct
Ohman lab

*Abbreviations: Ap , ampicillin resistance; Kan , kanamicin resistance; mSF, mini stabilizing fragment for replication in
s
P. aeruginosa; Suc , sucrose sensitive
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Ethanol precipitation of uronic acids
For recovery of uronic acids from P. aeruginosa strains, bacteria was cultured overnight
in liquid media (approximately 16 hours) at 37°C with shaking, then centrifuged at 10,000 x g
for one hour at 4°C to pellet bacterial cells. Supernatants were transferred to fresh centrifuge
tubes, 2.5 volumes of 95% ice cold ethanol were added, and then supernatants with ethanol were
centrifuged for 20 minutes at 4°C at 10,000 x g. Supernatants were decanted and uronic acid
pellets were re-suspended in 2-5 ml Milli-Q water by shaking at 30-37°C.

Uronic acid quantitation assay
The method used for uronic acid quantitation is based on that of Dische [55]. Required
reagents were prepared in advance where possible or on the day of use where required. A stock
borate reagent was prepared by dissolving 24.74 g of H3BO3 in 45 ml of 4 M KOH, brought to
100 ml by the addition of de-ionized water. A 0.1% carbazole solution was prepared by
dissolving 0.1 g of carbazole in 100 ml of ethanol. Both of these reagents were stored at room
temperature until use. On the day of use, a sulphuric acid-borate reagent (0.1 M H3BO3) was
made by combining 0.750 ml of stock borate solution with 30 ml of ACS analytical grade
H2SO4.
Triplicate samples were assayed for uronic acid content by cooling one ml of sulphuric
acid-borate reagent in glass tubes on ice for 2 minutes before adding 100 µl of alginate solution.
The solution was allowed to cool 2 minutes then vortexed and returned to ice for another 2
minutes. Thirty-three microliters of 0.1% carbazole solution was added, the samples vortexed,
and then returned to ice for 2 minutes. Sample tubes were then placed in a heat block and
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incubated at 55°C for 30 minutes before returning to ice. Absorbance was immediately read at
530 nm and the values recorded.
In order to equate observed spectrophotometric values with uronic acid amounts, a
standard curve was prepared by assaying concentrations of sodium alginate isolated from
Macrocystis pyrifera (Sigma) ranging from 10 µg/ml to 100 µg/ml. A 2 mg/ml stock solution of
sodium alginate was prepared by dissolving 0.040 g of sodium alginate in 20 ml of saline by
shaking at 37°C for one hour. A 100 µg/ml dilution of the sodium alginate stock solution was
made and then further diluted with saline to concentrations of 80, 60, 50, 40, 30, 20, and 10
µg/ml. One hundred microliters of each solution were assayed as outlined above and the
resulting absorbance readings were used to generate a standard curve.

Acetylation quantitation assay
The method used for quantitation of acetyl groups present in alginate solutions is based
on that described by Hestrin [56]. Required reagents were prepared within three hours of use. A
70 mM ferric perchlorate solution was prepared by dissolving 0.248 g of iron perchlorate in 5 ml
of 1 M perchloric acid and 5 ml of Milli-Q water. Alkaline hydroxylamine (0.35M
hydroxylamine, 0.75 M NaOH) was prepared by combining 0.243 g hydroxylamine, 0.750 ml 10
M NaOH, and 9.25 ml Milli-Q water.
Triplicate samples were assayed for acetyl group content by adding 500 µl of alkaline
hydroxylamine to 500 µl of alginate solution in a glass tube. The solution was mixed by
pipetting or vortexing and then incubated 10 minutes at 25°C. After incubation, 500 µl of 1 M
perchloric acid was added and the solution was mixed by pipetting or vortexing. Five hundred
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microliters of 70 mM ferric perchlorate was added to the solution and mixed by pipetting before
reading the absorbance of the solution at 500 nm.
In order to equate observed spectrophotometric values with amounts of acetyl group, a
standard curve was prepared by assaying ethyl acetate containing amounts of acetyl group
ranging from 0.0043 µg to 0.2150 µg. A 1:1000 dilution of 99.9% pure ethyl acetate (F.W.
88.11) was prepared containing 0.2150 µg of acetyl group (F.W. 43.04) per 500 µl, and then
further diluted to amounts of 0.1720, 0.1290, 0.0860, 0.0645, 0.0516, 0.0387, 0.0258, 0.0129,
and 0.0043 µg of acetyl group. Five hundred microliters of each solution were assayed as
outlined above and the resulting absorbance readings were used to generate a standard curve.

Construction and conjugation of algX complementation plasmid
The algX coding sequence was amplified by polymerase chain reaction from P.
aeruginosa FRD1 strain using primers 1 and 2 containing BspHI and HindIII restriction sites.
The reaction was fractionated on a 1% agarose gel, excised, and purified using the QIAquick Gel
Extraction Kit by Qiagen. The manufacturer’s protocol for gel purification using a
microcentrifuge was followed. Once purified, the product was digested using BspHI and HindIII
restriction enzymes from New England Biolabs. In brief, 5 µl NEB Buffer #2, 20 µl purified
algX PCR product, 1.5 µl BspHI, 1.5 µl HindIII, and 22 µl Milli-Q were incubated for three
hours at 37°C. The digestion reaction was heat inactivated by incubation at 65°C for 20 minutes,
fractionated on an agarose gel, and then excised and purified. Plasmid pMF54 was purified from
an overnight culture of JLP15 using the QIAprep® Miniprep Kit by Qiagen following the
manufacturer’s protocol for plasmid DNA purification using a microcentrifuge. After isolation,
the purified plasmid was digested using NcoI (generates 5’ overhang identical to that created by
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digestion with BspHI) and HindIII restriction enzymes from New England Biolabs. The
digestion reaction included 3 µl NEB Buffer #2, 20 µl purified pMF54, 1.5 µl NcoI, 1.5 µl
HindIII, and 4 µl Milli-Q and was incubated for two hours at 37°C. The digestion reaction was
then fractionated on an agarose gel, verified for digestion by comparison against uncut plasmid,
and excised and purified. Purified and digested algX was ligated into the pMF54 plasmid in a 20
µl overnight reaction at 16°C as follows: 4 µl purified algX, 2 µl pMF54, 1 µl T4 DNA Ligase
(New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 11 µl Milli-Q water.
Ligation reactions were transformed into chemically competent DH5α cells as follows: 8 µl of
ligation reaction was gently mixed into 100 µl of DH5α cells that had been thawed on ice.
Reaction was incubated on ice for 45 minutes and then cells were heat shocked for 40 seconds in
a 42°C water bath. Cells were returned to ice for one minute, 600 µl of Luria-Bertani media was
added, and cells were allowed to recover for one hour at 37°C with shaking. Cells were then
plated on Luria-Bertani plates with ampicillin (100 µg/ml) and incubated overnight at 37°C.
Resulting colonies were screened by PCR to confirm the presence of the algX insert. Successful
ligation and transformation for algX in pMF54 resulted in plasmid pJP12 and E. coli strain
JLP102.
Transfer of the pMF54 plasmid construct into the P. aeruginosa algX::Gm strain JLP4
was accomplished by conjugation. E. coli strain JLP3 containing the helper plasmid pRK2013
was used to facilitate the conjugation. Cultures of JLP4, JLP3, and JLP102 were started from
individual colonies and incubated in Luria-Bertani (LB) media, with antibiotics where
appropriate, at 37°C with shaking. After overnight incubation, 60 µl of the E. coli donor culture
(JLP102) was sub-cultured into 3 ml of fresh LB media with 100 ug/ml ampicillin, and 60 µl of
JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media supplemented with 30 µg/ml
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kanamycin. Both the donor and the helper sub-cultures were incubated at 37°C with shaking for
approximately five hours. For the recipient FRD1algX::Gm strain JLP4, one milliliter of
overnight culture was combined with one milliliter of fresh LB media and 40 µl of 1M NaNO3
and incubated without aeration for approximately 5 hours at 37°C. After incubation, 500 µl
FRD1algX::Gm recipient strain JLP4 was combined with 600 µl JLP3 helper strain and 600 µl of
the donor strain (JLP102) and cells were pelleted by centrifugation in a microcentrifuge at
>13,000 rpm for three minutes. Supernatant was removed, cells were washed with 500 µl of
saline, and centrifuged again at >13,000 rpm for three minutes. Cells were then resuspended in
30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C. After overnight incubation,
the cells were resuspended in three milliliters of saline and varying dilutions were spread on
plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar supplemented with 150 µg/ml of
carbenicillin. Plates were incubated overnight at 37°C and any resulting conjugants were restreaked on fresh ½ PIA and Luria plates with carbenicillin to confirm uptake of the plasmid.
Successful conjugation resulted in the P. aeruginosa strain JLP121 (FRD1algX::Gm strain with
algX expressed in trans on the pMF54 plasmid).
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Table 3. Oligonucleotides
Sequence (5’-3’)

Primer

Description

1

AlgX BspHI Forward

GCTATCCATCATGAATGAAAACCCGCACTTCCCG

2

AlgX HindIII Reverse

GCCATAAGCTTTTACCTCCCGGCCACCGAC

16

AlgF BspHI Forward

GCTATCCATCATGAACCCGATGACCCGCC

17

AlgF XhoI Reverse

GATAGCCTCGAGGTCCGCCTTCACCGGGCG

24

AlgX H176A Forward

GCGACCACGCCTGGACTC

25

AlgX H176A Reverse

GAGTCCAGGCGTGGTCGC

50

AlgF Outside Forward

GCCCGCCTGTATCCCGAG

51

AlgF Outside Reverse

GGCGTCGTGCTTCTTCAGTTC

52

AlgF C194S Forward

CGAGGTGGTCTCCCTGTACG

53

AlgF C194S Reverse

CGTACAGGGAGACCACCTCG

82

AlgF Outside Forward - Phos

GCCCGCCTGTATCCCGAG

83

AlgF Outside Reverse- Phos

GGCGTCGTGCTTCTTCAGTTC

88

AlgF Beta Oligo Forward

89

AlgF Beta Oligo Reverse

90

AlgG Beta Oligo Forward

91

AlgG Beta Oligo Reverse

92

AlgI Beta Forward

TGAATCGAATTCGGGCGTGGCGGG

93

AlgI Beta Reverse

ATCGGCGGATCCGCCGTCTCTCTCTCTAGAGC

94

AlgJ Beta Oligo Forward

95

AlgJ Beta Oligo Reverse

96

AlgX Beta Oligo Forward

97

AlgX Beta Oligo Reverse

AATTAGCGCCTGGCCGCCAGCCGCAACGATTGAACGAACACAGCCAAGGCT
GTTTACCCACGGGGCCGAGCGCCCCGCTGAAGAAGAAGCAACGGAGGAAT
ACCC
TCGCGGACCGGCGGTCGGCGTTGCTAACTTGCTTGTGTCGGTTCCGACAAA
TGGGTGCCCCGGCTCGCGGGGCGACTTCTTCTTCGTTGCCTCCTTATGGGC
TAG
AATTTTCAAGCCGGGCGACGCCTACGGGCCGGGCACCGACTCGACCATGCA
CCGCGCCTTCGTCGACTTCATCTGGCGCTTCTGAGCCCCGCGAGGAAACCG
GAC
AAGTTCGGCCCGCTGCGGATGCCCGGCCCGTGGCTGAGCTGGTACGTGGC
GCGGAAGCAGCTGAAGTAGACCGCGAAGACTCGGGGCGCTCCTTTGGCCT
GCTAG

AATTCGCCTGGCGCTGCTCCTGCTGTTCGCCGCCTCGGTGCTGAAGCTCTC
CGCGCAGAGCTACTCGCCATTCCTCTACTTCCAGTTCTGAGCGAGGCCCAC
GCC
GCGGACCGCGACGAGGACGACAAGCGGCGGAGCCACGACTTCGAGAGGC
GCGTCTCGATGAGCGGTAAGGAGATGAAGGTCAAGACTCGCTCCGGGTGCG
GCTAG
AATTAGCAGGACCAGATCCTCGACCTGCTGGTGCGCCAGGACAAGGCGGTG
CTGATCGACCCCGTGGAAAGCCAGGCCGAACTCCAGGACTGAGGACCCAGA
CGC
TCGTCCTGGTCTAGGAGCTGGACGACCACGCGGTCCTGTTCCGCCACGACT
AGCTGGGGCACCTTTCGGTCCGGCTTGAGGTCCTGACTCCTGGGTCTGCGC
TAG
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Construction and conjugation of algX H176A plasmid
The algX coding sequence was amplified in two portions by overlap extension
polymerase chain reaction from the P. aeruginosa FRD1 strain using primers 1 and 25, and
primers 2 and 24 (Table 3). Primers 1 and 2 contain BspHI and HindIII restriction sites,
respectively, and anneal to sequences at the beginning and end of the gene. Primers 24 and 25
are overlapping reverse complement primers containing mutations at the sequence encoding
amino acid 176. The sequence was engineered to alter two nucleotides in the codon 176
sequence from CAC to GCC.

After amplification the PCR products were fractionated on a 1%

agarose gel, excised, and purified using the QIAEX II Gel Extraction Kit by Qiagen according to
the manufacturer’s protocol. Another PCR reaction was performed to amplify the entire
mutanagized algX coding region using a mixture of the purified PCR reactions containing the
two mutanegized portions of the algX gene as template and primers 1 and 2. The PCR reaction
was fractionated on a 1% agarose gel, excised, and purified.
Purified algX H176A was ligated into pUC19 plasmid previously digested with SmaI
restriction enzyme (New England Biolabs) in a 20 µl overnight reaction at 16°C as follows: 4 µl
purified algX H176A, 1 µl pUC19, 1 µl T4 DNA Ligase (New England Biolabs); 2 µl 10X T4
DNA Ligase Reaction Buffer; and 12 µl Milli-Q water. Ligation reactions were transformed into
chemically competent DH5α cells as follows: 8 µl of ligation reaction was gently mixed into
100 µl of DH5α cells that had been thawed on ice. Reaction was incubated on ice for 45 minutes
and then cells were heat shocked for 40 seconds in a 42°C water bath. Cells were returned to ice
for one minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for
one hour at 37°C with shaking. Cells were then plated on Luria-Bertani plates with ampicillin
(100 µg/ml) and incubated overnight at 37°C. Resulting colonies were screened by PCR to
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confirm the presence of the algX H176A insert. Successful ligation and transformation for algX
H176A in pUC19 resulted in plasmid pJP13 and E. coli strain JLP106.
To verify that the sequence encoding amino acid 176 in algX had been mutated from
CAC to GCC and that there were no other unintentional mutations in the coding sequence, strain
JLP106 was cultured overnight and plasmid pJP13 was purified for sequencing using the
QIAprep® Miniprep Kit (Qiagen). Sequencing was performed by the VCU Nucleic Acids
Research Facilities DNA Sequencing Core (Richmond, VA) and MWG Biotech (High Point,
NC) on both algX H176A from strain JLP106 (and two additional clones) and wild-type algX
isolated from P. aeruginosa strain FRD1 for comparison purposes. Sequencing confirmed the
presence of the engineered algX H176A mutation and identified four sequence differences in the
P. aeruginosa FRD1 algX sequence and the published P. aeruginosa PAO1 sequence. Three of
these divergent nucleotides resulted in no change to the FRD1 amino acid sequence compared to
that of PAO1, while the fourth resulted in an amino acid change between the two strains.
Following sequence verification, purified pJP13 was digested with BspHI and HindIII
restriction enzymes (New England Biolabs) in a standard 30 µl reaction using 1.5 µl of each
enzyme and 20 µl of purified plasmid. The digestion reaction was fractionated on an agarose
gel, and the algX H176A fragment was excised and purified. The purified fragment was ligated
into plasmid pMF54, previously digested with NcoI (generates 5’ overhang identical to that
created by digestion with BspHI) and HindIII restriction enzymes (New England Biolabs), in a
standard 20 µl overnight ligation reaction. Chemically competent E. coli DH5α cells were
transformed with the ligation reaction as follows: 8 µl of ligation reaction was gently mixed into
100 µl of DH5α cells that had been thawed on ice. Reaction was incubated on ice for 45 minutes
and then cells were heat shocked for 40 seconds in a 42°C water bath. Cells were returned to ice
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for one minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for
one hour at 37°C with shaking. Cells were then plated on Luria-Bertani plates with ampicillin
(100 µg/ml) and incubated overnight at 37°C. Resulting colonies were screened by PCR to
confirm the presence of the algX H176A insert. Successful ligation and transformation for algX
H176A in pMF54 resulted in plasmid pJP14 and E. coli strain JLP131.
Transfer of the pMF54 plasmid construct into the P. aeruginosa algX::Gm strain JLP4
was accomplished by conjugation. E. coli strain JLP3 containing the helper plasmid pRK2013
was used to facilitate the conjugation. Cultures of JLP4, JLP3, and JLP131 were started from
individual colonies and incubated in Luria-Bertani (LB) media, with antibiotics where
appropriate, at 37°C with shaking. After overnight incubation, 60 µl of the E. coli donor culture
(JLP131) was sub-cultured into 3 ml of fresh LB media with 100 µg/ml ampicillin, and 60 µl of
JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media supplemented with 30 µg/ml
kanamycin. Both the donor and the helper sub-cultures were incubated at 37°C with shaking for
approximately five hours. For the recipient FRD1algX::Gm strain JLP4, one milliliter of
overnight culture was combined with one milliliter of fresh LB media and 40 µl of 1M NaNO3
and incubated without aeration for approximately 5 hours at 37°C. After incubation, 500 µl
FRD1algX::Gm recipient strain JLP4 was combined with 600 µl JLP3 helper strain and 600 µl of
the donor strain (JLP131) were combined and cells were pelleted by centrifugation in a
microcentrifuge at >13,000 rpm for three minutes. Supernatant was removed, cells were washed
with 500 µl of saline, and centrifuged again at >13,000 rpm for three minutes. Cells were then
resuspended in 30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C. After
overnight incubation, the cells were resuspended in three milliliters of saline and varying
dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar

26

supplemented with 150 µg/ml of carbenicillin. Plates were incubated overnight at 37°C and any
resulting conjugants were re-streaked on fresh ½ PIA and Luria plates with carbenicillin to
confirm uptake of the plasmid. Successful conjugation resulted in the P. aeruginosa strain
JLP135 (FRD1algX::Gm strain with algX H176A expressed in trans on the pMF54 plasmid).

Isolation of ribonucleic acid
Overnight bacterial cultures were sub-cultured at a dilution of 1:100 into 20 ml of fresh
media and grown to an OD600 of approximately 0.8. Cells were harvested from 10 ml of culture
by centrifugation at 10,000 x g for 15 minutes at 4°C. RNA was isolated from bacterial cells
using TRIzol® reagent by Invitrogen and following the manufacturer’s protocol. In brief, cells
were lysed in 1 ml of TRIzol® reagent by repetitive pipetting and then incubated five minutes at
room temperature (~25°C). Two hundred µl of chloroform was added, samples were shaken by
hand for 15 seconds, and then incubated at room temperature for 2 minutes. Samples were
centrifuged at 12,000 x g for 15 minutes at 4°C to separate the mixture into a phenol-chloroform
phase, an interphase, and an aqueous phase. The aqueous phase was removed and RNA was
precipitated from it using 0.5 ml of isopropyl alcohol. Samples were incubated at room
temperature for 10 minutes and then centrifuged at 12,000 x g for 15 minutes at 4°C. The
supernatant was removed from the samples and the RNA pellet was washed with 1 ml of 75%
ethanol. RNA was re-suspended by vortexing and the samples were centrifuged at 7,500 x g for
5 minutes at 4°C. The RNA pellet was air-dried for 6 minutes and redissolved in 30 µl RNasefree water by pipetting followed by incubation at 55°C for 10 minutes.
To facilitate efficient removal of any contaminating DNA, nucleic acid quantitation was
performed on RNA samples by measuring absorbance at 260/280 nm, and, where necessary,
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samples were diluted to a concentration of approximately 500 µg/ml. RNA was then treated
twice using the Ambion® DNA-free™ Kit (Applied Biosystems) and the manufacturer’s
rigorous DNase treatment protocol as follows. Three microliters of 10X DNase I Buffer and 1.5
µl of rDNase I were added to 30 µl RNA samples, mixed, and incubated at 37°C. After 30
minutes, an additional 1.5 µl of rDNase I was added and the samples were returned to 37°C for
another 30 minutes. Upon completion of the 37°C incubation, 6 µl of DNase Inactivation
Reagent was added and the samples were incubated at room temperature for two minutes with
occasional mixing. Samples were centrifuged in a standard tabletop centrifuge for 1.5 minutes at
13,000 rpm to pellet DNase Inactivation Reagent and supernatants containing treated RNA were
transferred to fresh tubes. Samples were re-quantitated after two treatments to ensure adequate
260/280 ratios and for use in downstream applications.
RNA was stored at -80°C until use.
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Table 4. Real-time primers
Primer

Description

Sequence (5’-3’)

62

algD RT Forward

ACGCGGTCATGAAGTCATTGGT

63

algD RT Reverse

ACGATACGTCGGAGTCCAGCAC

70

oprF RT Forward

CAGCTGGACGTGAAGTTCGA

71

oprF RT Reverse

GAAGTCAGCCAGGTTCTTGATGT

74

algI RT Forward

CCTCTGCGTGCTCGGGTACT

75

algI RT Reverse

GATGTGGGTCAGCACGAACG

80

algA RT Forward

CCATGATGATCGCCCACAAG

81

algA RT Reverse

ACCTCGCAGTGGTTCTGGGT

108

algG RT Forward

CGCGACAACATCGTCTACGG

109

algG RT Reverse

TGATGCCGTGCTTCTTCCTG
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Real-time polymerase chain reaction
Complimentary DNA (cDNA) for use in real-time polymerase chain reaction (RT-PCR)
was made from previously isolated RNA samples using Applied Biosystems™’ TaqMan®
Reverse Transcription Reagents according to the manufacturer’s protocol. In brief, the following
were combined for a 50 µl reaction: 5 µl 10X TaqMan RT Buffer, 11 µl 25mM magnesium
chloride, 10 µl dNTP mixture (10 mM per dNTP), 0.5 µl gene specific reverse primer (50 µM), 1
µl RNase Inhibitor, 1.25 µl Multiscribe Reverse Transcriptase (50 U/µl) (except for no reverse
transcriptase controls), 0.75 µg RNA, and RNase-free water to make 50 µl total volume.
Reverse transcription was performed in a PTC-200 Peltier thermal cycler (MJ Research) using
the following parameters: 10 minutes at 25°C, 30 minutes at 48°C, and 5 minutes at 95°C.
Specificity of gene specific primers and absence of contaminating DNA was verified by
PCR amplification of cDNA using gene specific primers, AmpliTaq® DNA polymerase (Applied
Biosystems), and standard PCR cycling parameters. PCR reactions were fractionated on 1%
agarose gels and examined for appropriately sized single bands for reactions using gene specific
primers or for no bands in the no reverse transcriptase controls.
Following verification, gene specific cDNA was used in RT-PCR temperature gradients
to determine primer efficiencies for each gene of interest. RT-PCR was performed using the
MyiQ2 Two-Color Real-Time PCR Detection System (Bio-Rad) and SensiMix™ Plus SYBR &
Fluorescein Kit (Quantace). Serial dilutions of cDNA ranging from 50 ng to 6.25 ng were added
to 12.5 µl SensiMix™, 2 µl gene specific forward primer (5 µM), 2 µl gene specific reverse
primer (5 µM), and 6.5 µl water for a total volume of 25 µl. Samples were processed in 96-well
plates at a temperature range from 55-65°C with cycling parameters as follows: 3 minutes at
95°C once; 10 seconds at 95°C, 30 seconds at 55-65°C, and 15 seconds at 72°C repeated 40
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times; and 15 seconds at 55-95°C in 0.5 degree increments (to generate melt curve) once. Realtime PCR was then performed on each gene in triplicate based on the optimum efficiency
determined by the temperature gradients using 6.25ng of cDNA and the cycling parameters
outlined above. Primer efficiencies ranged from 91.1 to 103.6.

Construction of reporter fusion plasmids for use in beta-galactosidase assays
Multiple strategies were employed in the construction of the strains used in the betagalactosidase assays based on the size of the region to be examined and availability of previously
generated constructs.
For the genes algG, algX, algJ, and algF, in which the area to be investigated was
approximately 100 base pairs in size, oligonucleotides were constructed by Integrated DNA
Technologies, Inc. identical to the sequences 100 base pairs upstream of the genes. The 5’ end
of the forward strands were engineered to include aatt overhangs and the 5’ end of the reverse
strands to include gatc overhangs so that when annealed together the double-stranded 100 bp
fragments would contain overhangs complimentary to DNA digested with EcoRI and BamHI
restriction enzymes.
The eight four nanomole oligonucleotides were resuspended in Milli-Q ultrapure water to
yield a concentration of 1µg/µl. Complimentary oligonucleotides were annealed by heating at
85°C for 3 minutes in a 50 µl annealing reaction and then allowing them to cool very slowly over
approximately 1.5 hours. The annealing reaction included 2 µl forward oligonucleotide, 2 µl
reverse oligonucleotide, 5 µl 10X annealing buffer (1 ml 1M Tris, 2 ml 5M NaCl, 200 µl 0.5M
EDTA, and 6.8 ml Milli-Q water) and 41 µl Milli-Q water. Successful annealing of the pairs
was verified by side-by-side visualization of ethidium bromide stained single-strand and
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annealed oligonucleotides on a 1% agarose gel. Annealed oligonucleotides were ligated into
plasmid pSS269 (isolated and purified from strain JLP149) digested with restriction enzymes
EcoRI-HF and BamHI-HF in a 20 µl overnight reaction at 16°C as follows: 0.5 µl annealed
oligonucleotide algG, algX, algJ, or algF; 1 µl pSS269 (2 µl for algG oligonucleotide); 1 µl T4
DNA Ligase (New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 15.5 µl
Milli-Q water (14.5 µl for algG oligonucleotide). Ligation reactions were transformed into
Subcloning Efficiency™ DH5α™ Competent Cells from Invitrogen following the standard
manufacturer’s protocol. In brief, 2.5 µl of individual ligation reactions were gently mixed into
50 µl of DH5α cells that had been thawed on ice. Reactions were incubated on ice for 30
minutes and then cells were heat shocked for 20 seconds in a 42°C water bath. Cells were
returned to ice for two minutes, 950 µl of Luria-Bertani media was added, and cells were
allowed to recover for one hour at 37°C with shaking. Cells were then plated on Luria-Bertani
plates with ampicillin (100 µg/ml) and incubated overnight at 37°C. Colonies were screened by
PCR to confirm the presence of the appropriate insert. Successful ligations and transformations
for algG, algX, algJ and algF upstream regions resulted in plasmids pJP16, pJP17, pJP18, and
pJP19, and E. coli strains JLP159, JLP170, JLP167, and JLP165, respectively.
To amplify the upstream region of the algI gene, primers were designed with an EcoRI
restriction site at the 5’ end of the forward strand (Primer 92) and a BamHI restriction site at the
5’ end of the reverse strand (Primer 93) (Table 3). Primers were designed to amplify
approximately 250 base pairs upstream of the start of the algI coding region and were used in a
PCR reaction using Phusion High-Fidelity DNA Polymerase (Finnzymes) and Pseudomonas
aeruginosa FRD1 cells to amplify the specified regions with EcoRI and BamHI restriction sites.
The reaction was fractionated on a 1% agarose gel and a band of the appropriate size was excised
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and purified using the QIAquick Gel Extraction Kit by Qiagen. The manufacturer’s protocol for
gel purification using a microcentrifuge was followed. Once purified, the product was
sequentially digested using BamHI-HF then EcoRI-HF high fidelity restriction enzymes from
New England Biolabs. In brief, 4 µl NEB Buffer #4, 10 µl purified PCR product, 1 µl BamHIHF, and 24 µl Milli-Q were incubated for one hour at 37°C. An additional 1 µl BamHI-HF was
added and the reaction was incubated another hour at 37°C. The digestion was fractionated on a
1% agarose gel, excised, and purified using the above referenced Qiagen kit. A second digest
was performed on the purified sample as previously outlined, using EcoRI-HF in place of
BamHI-HF. After purification, the algI upstream fragment was ligated into pSS269 and
transformed into DH5α cells as outlined previously for upstream regions of algG, algX, algJ, and
algF, with the exception of the amounts of insert, vector, and water used in the ligation reaction
(1 µl algI insert, 2 µl pSS269, 14 µl Milli-Q). Successful ligation and transformation for the algI
upstream region resulted in plasmid pJP20, and E. coli strain JLP162.
The E. coli DH5α strain LW1569 containing the plasmid pLW149a was previously
created in the Ohman lab by ligating the region upstream of algD (approximately 930 base pairs)
into the SmaI site of plasmid pSS269. No manipulation of this construct was required before
conjugation of the plasmid into the P. aeruginosa FRD1 strain.
Transfer of the pSS269 plasmid constructs into the P. aeruginosa FRD1 strain (JLP7)
was accomplished by conjugation. E. coli strain JLP3 containing the helper plasmid pRK2013
was used to facilitate the conjugation. Cultures of FRD1, JLP3, and JLP159 (algG upstream),
JLP170 (algX upstream), JLP167 (algJ upstream), JLP165 (algF upstream), JLP162 (algI
upstream), and LW1569 (algD upstream) were started from individual colonies and incubated in
Luria-Bertani (LB) media, with antibiotics where appropriate, at 37°C with shaking. After
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overnight incubation, 60 µl of the E. coli donor cultures (JLP159, JLP170, JLP167, JLP165,
JLP162, and LW1569) were sub-cultured into 3 ml of fresh LB media with 100 ug/ml ampicillin.
For each conjugation, 60 µl of JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB
media supplemented with 30 µg/ml kanamycin. Both the donor and the helper sub-cultures were
incubated at 37°C with shaking for approximately five hours. For the recipient FRD1 strain
(JLP7), one milliliter of overnight culture was combined with one milliliter of fresh LB media
and 40 µl of 1 M NaNO3 for each conjugation and incubated without aeration for approximately
5 hours at 37°C. After incubation, 500 µl FRD1 recipient strain was combined with 600 µl JLP3
helper strain and 600 µl of each donor strain (JLP159, JLP170, JLP167, JLP165, JLP162, and
LW1569) were combined and cells were pelleted by centrifugation in a microcentrifuge at
>13,000 rpm for three minutes. Supernatant was removed, cells were washed with 500 µl of
saline, and centrifuged again at >13,000 rpm for three minutes. Cells were then resuspended in
30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C. After overnight incubation,
the cells were resuspended in three milliliters of saline and varying dilutions were spread on
plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar supplemented with 150 µg/ml of
carbenicillin. Plates were incubated overnight at 37°C and any resulting conjugants were restreaked on fresh ½ PIA and Luria plates with carbenicillin to confirm uptake of the plasmid.
Successful conjugations resulted in the following FRD1 strains carrying the pSS269 plasmid
constructs: JLP173 (algG upstream), JLP184 (algX upstream), JLP179 (algJ upstream), JLP182
(algF upstream), JLP162 (algI upstream), and JLP196 (algD upstream).
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Beta-galactosidase assay
Overnight cultures of each strain containing upstream gene sequences in plasmid pSS269
were grown in Luria-Bertani media and then subcultured at a ratio of 1:100 into fresh media and
grown to an O.D.600 of approximately 0.8. One hundred microliters of cell culture was added to
900 µl of Z buffer (0.06M Na2HPO4, 0.04M NaH2PO4 · H2O, 0.01M KCl, 0.001M MgSO4 ·
7H2O, 0.05M β-mercaptoethanol), 20 µl 0.1% SDS, and 40 µl CHCl3 and vortexed to
permeabilize cells. Cells were incubated 5 minutes in a 28°C water bath with periodic vortexing.
Following incubation, 200 µl of 4mg/ml o-nitrophenyl-beta-D-galactopyranoside (ONPG) in Z
buffer was added to cells, cells were vortexed, and timing was started. Five hundred microliters
of stop solution (1M Na2CO3) was added upon the cell mixture turning a light yellow or at 30
minutes, whichever occurred first. The cell mixture was allowed to rest at 28°C for the CHCl3 to
settle and 1 ml of the mixture was removed and absorbance at OD420 and OD550 was read. Blank
samples consisted of all components except cells and CHCl3. Results were reported in Miller
units calculated using the formula 1000 x [OD420 – (1.75 x OD550)]/[time (minutes) x volume
(ml) x OD600] where time was equal to the minutes it took the reaction to occur and volume was
equal to the amount of cell culture added to the reaction.

5’ Rapid Amplification of cDNA Ends (5’ RACE)
The 5’ RACE technique was chosen to determine the mRNA start site of the promoter
regions upstream of the algG and algI alginate biosynthesis genes. For this purpose the
SMARTer™ RACE cDNA Amplification Kit was purchased from Clontech.
5’ RACE-ready complimentary DNA (cDNA) was made using the SMARTer™ RACE
kit according to the manufacturer’s protocol. This process adds an extended tail at the 5’ end of
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the cDNA that enables amplification using a Universal Primer Mix included in the SMARTer™
RACE kit. The reverse algG and algI primers used for the real-time PCR analysis were used to
generate the 5’ RACE-ready cDNA instead of the Random Primer Mix or CDS Primers (for use
with RNA possessing poly A tails) included in the kit.
After the generation of RACE-ready cDNA, 5’RACE was performed according to the
manufacturer’s protocol. As Advantage®-GC 2 Polymerase Mix was used for this process
instead of Advantage® 2 PCR Mix, some modification of the protocol was necessary to allow for
use of this polymerase. Resulting reactions were fractionated on a 1% agarose gel, excised and
purified using the QIAquick Gel Extraction Kit (Qiagen).
The TOPO TA Cloning® kit was used to ligate the purified DNA into the pCR®2.1TOPO vector and transform the reaction into One Shot® TOP10 cells. Transformants were
selected by plating on Luria-Bertani plates with ampicillin (100 µg/ml) and X-gal (40 mg/ml).
Seven colonies were selected and cultured in Luria-Bertani broth with ampicillin overnight at
37°C with shaking. Plasmids were isolated and purified then submitted to Eurofins MWG
Operon (Huntsville, AL) for sequencing of the inserts.

Modification of Strep-II tag® vector pASK-IBA63b for use in Pseudomonas
The vector pASK-IBA63b-plus was purchased from IBA GmbH and altered for use in
Pseudomonas. Purified plasmid was transformed into E. coli DH5α cells following a standard
protocol. In brief, 0.5 µl of pASK-IBA63b-plus plasmid was gently mixed into 100 µl of DH5α
cells that had been thawed on ice. Reaction was incubated on ice for 45 minutes and then cells
were heat shocked for 40 seconds in a 42°C water bath. Cells were returned to ice for one
minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for one hour
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at 37°C with shaking. Cells were then plated on Luria-Bertani plates with ampicillin (100
µg/ml) and incubated overnight at 37°C. A colony was selected from the resulting
transformants, re-streaked, cultured in liquid media, and frozen at -80°C as strain JLP30.
Plasmid was isolated from an overnight JLP30 culture using the QIAprep® Miniprep Kit
(Qiagen) and digested with SpeI restriction enzyme (New England Biolabs) as follows: 20 µl of
pASK-IBA63b vector, 5 µl NEB Buffer #2, 3 µl SpeI, and 3 µl Milli-Q, incubated for three
hours at 37°C. The digestion reaction was then fractionated on an agarose gel, verified for
digestion by comparison against uncut plasmid, excised, and purified using QIAEX II Gel
Extraction Kit (Qiagen).
Strain JLP33 was cultured overnight and the P. aeruginosa oriT -containing plasmid
pSS125 was isolated and purified. Purified pSS125 was digested with BamHI restriction enzyme
(as outlined above for SpeI digestion of pASK-IBA63b vector) then fractionated, verified,
excised and purified. Both the digested pASK-IBA63b vector and the oriT fragment were
treated with DNA Polymerase I, Large (Klenow) Fragment (New England Biolabs) to generate
blunt ends. In brief, 20 µl of vector or oriT fragment, 3 µl NEB Buffer #2, 1 µl Klenow, 4 µl
0.25 mM dNTPs, and 2 µl Milli-Q, were incubated for 15 minutes at 25°C, and then the reaction
was stopped by the addition of 0.6 µl 0.5 M EDTA and incubation at 75°C for 20 minutes. The
reactions were fractionated on an agarose gel, excised, and purified before ligation.
The oriT fragment was ligated into pASK-IBA63b in a standard ligation reaction using
T4 DNA ligase (New England Biolabs) and transformed into chemically compentent E. coli
DH5α cells. Cells were plated on Luria-Bertani plates with ampicillin (100 µg/ml) and
incubated overnight at 37°C. Resulting colonies were screened by PCR to confirm the presence
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of the oriT insert. Successful ligation and transformation for oriT in pASK-IBA63b resulted in
plasmid pJP2 and E. coli strain JLP35.
Plasmid was isolated from an overnight JLP35 culture and digested with NaeI restriction
enzyme (New England Biolabs) in a standard reaction. The digestion reaction was then
fractionated on an agarose gel, verified for digestion by comparison against uncut pJP2 plasmid,
excised, and purified.
Strain JLP32 was cultured overnight and plasmid pSS124 containing the P. aeruginosa
mini stabilizing fragment (mSF) was isolated and purified. Purified pSS124 was digested with
SphI restriction enzyme in a standard reaction then fractionated on an agarose gel, verified for
digestion by comparison against uncut pSS124 plasmid, excised, and purified.
The digested mSF fragment was treated with DNA Polymerase I, Large (Klenow)
Fragment (New England Biolabs) as previously outlined to generated blunt ends. The reaction
was fractionated on an agarose gel, excised, and purified before ligation.
A standard ligation of mSF and pJP2 was performed and transformed into chemically
competent DH5α cells. Cultures of the resulting colonies were examined for insertion of the 1.2
kb mSF by a ‘Quick-Check’ method [57]. Briefly, 25 µl phenol, 25 µl chloroform, and 10 µl
loading dye were combined in a microcentrifuge tube. One hundred microliters of the
transformant E. coli culture was added and the mixture was vortexed for 10 seconds. Mixtures
were spun for 3 minutes in a microcentrifuge at >13,000 rpm to fractionate. Thirty microliters of
the supernatant was loaded into an agarose gel and fractionated along with uncut pJP2 plasmid
for size comparison purposes. Plasmid containing the insert was designated pJP5 and the E. coli
strain containing it was designated JLP43.
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The algF coding region was amplified from FRD1 using Primers 16 and 17 to generate
BspHI and XhoI restriction sites flanking the gene. The resulting PCR product was digested
with BspHI and XhoI in a standard digestion reaction, fractionated, and purified.
Plasmid pJP5, isolated and purified from an overnight culture of JLP43, was digested
with restriction enzymes NcoI and XhoI. Following purification, digested pJP5 and BspHI and
XhoI digested algF were combined in a standard overnight ligation reaction. Chemically
compentent E. coli DH5α cells were transformed with the ligation reaction and cells were plated
on Luria-Bertani plates with ampicillin (100 µg/ml) and incubated overnight at 37°C. Resulting
colonies were screened by the Quick-Check method and by PCR to confirm the presence of the
algF insert. Successful ligation and transformation of algF into pJP5 resulted in plasmid pJP11
and E. coli strain JLP65.
Transfer of the pJP11 plasmid construct into the P. aeruginosa FRD1 and FRD1175
(ΔalgF) strains was accomplished by conjugation. E. coli strain JLP3 containing the helper
plasmid pRK2013 was used to facilitate the conjugation. Cultures of FRD1, FRD1175, JLP3,
and JLP65 were started from individual colonies and incubated in Luria-Bertani (LB) media,
with antibiotics where appropriate, at 37°C with shaking. After overnight incubation, 60 µl of
the E. coli donor culture (JLP65) was sub-cultured into 3 ml of fresh LB media with 100 ug/ml
ampicillin, and 60 µl of JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media
supplemented with 30 µg/ml kanamycin. Both the donor and the helper sub-cultures were
incubated at 37°C with shaking for approximately five hours. For the recipient FRD1 and
FRD1175 strains, one milliliter of overnight culture was combined with one milliliter of fresh
LB media and 40 µl of 1M NaNO3 and incubated without aeration for approximately 5 hours at
37°C. After incubation, 500 µl of each FRD recipient strain (FRD1 and FRD1175) was
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combined with 600 µl JLP3 helper strain and 600 µl of the donor strain (JLP65) and cells were
pelleted by centrifugation in a microcentrifuge at >13,000 rpm for three minutes. Supernatant
was removed, cells were washed with 500 µl of saline, and centrifuged again at >13,000 rpm for
three minutes. Cells were then resuspended in 30 µl of saline, spotted on a Luria agar plate, and
incubated at 30°C. After overnight incubation, the cells were resuspended in three milliliters of
saline and varying dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and
Luria agar supplemented with 150 µg/ml of carbenicillin. Plates were incubated overnight at
37°C and any resulting conjugants were re-streaked on fresh ½ PIA and Luria plates with
carbenicillin to confirm uptake of the plasmid. Successful conjugation resulted in the P.
aeruginosa strains JLP98 (FRD1 with algF Strep-II tag expressed in trans from plasmid pJP11)
and JLP113 (FRD1175 ΔalgF strain with algF Strep-II tag expressed in trans from plasmid
pJP11).

AlgF-Strep-II tagged protein induction and purification
The optimal growth point for maximum induction of AlgF-Strep-II tagged proteins was
determined empirically to be at an OD600 of 0.2. Bacterial cultures to be induced were subcultured from overnight cultures at a ratio of 1:100 and incubated at 37°C with shaking until the
optimum OD was reached. Protein expression was induced by addition of 0.1 µl of
anhydrotetracyline (aTc) per 1 ml of culture. Incubation with shaking was continued for three
hours then cells were harvested by centrifugation at 10,000 x g at 4°C and cell pellets were
frozen overnight before purification. Bugbuster® HT Protein Extraction Reagent (Novagen) was
used for cell lysis according to the manufacturer’s protocol.
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Following lysis AlgF-Strep-II tagged proteins were purified by gravity-flow column
chromatography using Strep-Tactin sepharose resin and following the manufacturer’s protocol.
Buffers for protein purification as well as anhydrotetracyline for protein induction were
purchased from IBA BioTAGnology.

SDS-PAGE
Various purified bacterial proteins and bacterial culture lysates were subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for analysis. Samples were
loaded into either precast Criterion Tris-HCL polyacrylamide gels (Bio-Rad) or polyacrylamide
gels were cast as outlined below.
Large 12% polyacrylamide gels were prepared by mixing 12.2 ml Milli-Q water, 8.75 ml
4X Separating Buffer (1.5 M Tris-HCl, 0.4% SDS, pH 8.8), and 14.0 ml 30% acrylamide. Two
hundred fifty microliters 10% ammonium persulfate and 10 µl TEMED were added, mixed by
swirling, and poured between clamped glass plates. Milli-Q water was slowly layered on top of
acrylamide mixture and gel was allowed to polymerize. Water was removed and a stacking gel
composed of 9 ml Milli-Q water, 3.75 ml 4X Stacking Buffer (0.5 M Tris-HCl, 0.4% SDS, pH
6.8), 1.95 ml 30% acrylamide, 200 µl 10% ammonium persulfate, and 10 µl TEMED was added
with an appropriate comb.
Samples were typically loaded with a 2X reducing (0.125 M Tris-HCl pH 6.8, 4% SDS,
5% β-mercaptoethanol, 20% glycerol, and 0.2% bromophenol blue) or non-reducing buffer
(0.125 M Tris-HCl pH 6.8, 4% SDS, 20% glycerol, and 0.2% bromophenol blue) depending on
the application, and Precision Plus Protein Dual Color Standards (Bio-Rad) were used for
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molecular weight estimation. SDS-PAGE gels were typically electrophoresed at 200 volts for
50-60 minutes.

Immunoblot analysis
After bacterial proteins or bacterial cell lysates were subjected to sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), samples were transferred to polyvinylidene
difluoride (PVDF) membrane (Immun-Blot PVDF Membrane, Bio-Rad). Before alignment with
the polyacrylamide gel, the PVDF membrane was wet using 100% methanol and then
equilibrated in transfer buffer for approximately 5 minutes. Transfer to the membrane was
typically accomplished by applying 100 volts for approximately one hour using a tank transfer
system.
After transfer, membranes were blocked in Tris-buffered saline (TBS) with 0.5 % Tween
and 0.5 % bovine serum albumin (BSA) overnight at 4°C or for at least one hour at room
temperature with rocking. For Strep-II tagged proteins, primary antibody was typically used at a
1:2000 concentration (IBA) in blocking buffer (TBST with BSA) when using a goat anti-mouse
HRP-conjugated secondary antibody, and a 1:10,000 concentration when using a rabbit antimouse horseradish peroxidase (HRP)-conjugated secondary antibody. Typical primary antibody
incubation was one hour at room temperature with rocking. Membranes were washed three
times with TBST for 10 – 15 minutes each after incubation with primary antibody for one hour
with rocking. Secondary antibody was added at a concentration of 1:40,000 and membranes
were incubated for one hour at room temperature with rocking. After removal of secondary
antibody, membranes were washed three times and SuperSignal West Pico Chemiluminescent
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Substrate (Pierce) was added for five minutes with rocking. Reactive proteins were visualized
by exposure of the membrane to x-ray film for variable lengths of time.

2-D Redox SDS-PAGE
Affinity purified AlgF-Strep-II tagged protein was separated by SDS-PAGE on a 12%
polyacrylamide gel in the first dimension using non-reducing buffer. The lane was excised and
soaked in 2X reducing SDS buffer with shaking for 30 minutes. (An identical lane was also
excised but left in buffer until the staining process.) The polyacrylamide strip (gel lane) was
rinsed with running buffer and loaded into a large well in a second polyacrylamide gel (either
12% or 10-20% gradient). The gel was run as normal with proteins moving from the gel strip in
the well into the second gel.
When the dye front reached the bottom of the gel, current was discontinued and the
separating gel and identical gel strip saved from the first gel were stained using the Bio-Rad
Silver Stain Plus Kit according to the manufacturer’s protocol.

Protein identification by mass spectrometry analysis
Eight identical 2-D Redox SDS-PAGE gels of purified AlgF-Strep-II tagged protein were
run and stained with mass spectrometry compatible SilverSNAP Silver Stain Kit II (Pierce).
After gels were washed overnight in Milli-Q water, three select protein spots from each gel were
excised, pooled and then treated with a reduction/alkylation procedure to increase peptide
recovery (Nature Protocols, 1 (6), 2856 – 2860, 2006). Pooled gel slices were placed in a
microcentrifuge tube and 500 µl of acetonitrile was added. Slices were incubated at room
temperature for 10 minutes and then spun in a microcentrifuge to allow removal of the liquid.
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Fifty microliters of 10 mM DTT in 100 mM ammonium bicarbonate was added and the samples
were incubated for 30 minutes at 56°C. Samples were allowed to cool to room temperature and
500 µl of acetonitrile was added. After 10 minute room temperature incubation, samples were
spun and liquid was removed. Fifty microliters of 55 mM iodoacetamide in 100 mM ammonium
bicarbonate was added and the samples were incubated at room temperature for 20 minutes in
the dark. The iodoacetamide solution was removed and the gel slices were incubated in 500 µl
of acetonitrile. Samples were spun to remove liquid and 100 µl of a 1:1 (volume/volume) 100
mM ammonium bicarbonate/acetonitrile mixture was added. Samples were incubated for 30
minutes with occasional vortexing. Five hundred µl of acetonitrile was added and samples were
incubated at room temperature with occasional vortexing until gel slices became white and
shrunk. Samples were spun in a microcentrifuge, liquid was removed and samples were stored at
-20°C until shipping.
Samples were submitted to Applied Biomics, Hayward, California, for protein
identification by mass spectrometry analysis.

Construction of algF C194S plasmid
The algF coding sequence was amplified in two portions by overlap extension
polymerase chain reaction from the P. aeruginosa FRD1 strain using primers 50 and 53, and
primers 51 and 52 (Table 3). Phusion™ High-Fidelity DNA Polymerase (Finnzymes/New
England Biolabs) with GC buffer was used to amplify the products following the manufacturer’s
recommended PCR protocol. Use of Phusion™ polymerase results in a blunt end PCR product
which can be ligated directly into a SmaI digested vector. Primers 50 and 51 anneal to sequences
approximately 800 bp upstream of the beginning of the algF gene and 800 bp downstream of the
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end of the gene, respectively, to allow for recombination into the genome. Primers 51 and 52 are
overlapping reverse complement primers containing mutations at the sequence encoding amino
acid 194. The sequence was engineered to alter one nucleotide in the codon 194 sequence from a
G to a C resulting in the triplet TCC, coding for serine, instead of TGC encoding cysteine. After
amplification the PCR products were fractionated on a 1% agarose gel, excised, and purified
using the QIAquick Gel Extraction Kit by Qiagen. The manufacturer’s protocol for gel
purification using a microcentrifuge was followed. Another PCR reaction was performed to
amplify the entire mutagenized algF coding region using a mixture of the purified PCR reactions
containing the two mutagenized portions of the algF gene as template and phosphorylated
primers 82 and 83 (identical to primers 50 and 51 but engineered with added phosphates). The
PCR reaction was fractionated on a 1% agarose gel, excised, and purified.
Plasmid pUC19 was purified from E. coli strain JLP54 using the QIAprep® Miniprep Kit
(Qiagen) according to the manufacturer’s protocol and the purified plasmid was digested using
the SmaI restriction enzyme from New England Biolabs in a typical digestion reaction. The
digestion reaction was then fractionated on an agarose gel, verified for digestion by comparison
against uncut plasmid, and excised and purified. The digested plasmid was then treated with
Antarctic Phosphatase (New England Biolabs) to dephosphorylate the vector in a reaction
including 20 µl pUC19, 2.3 µl 10X Antarctic Phosphatase Reaction Buffer, and 1 µl
phosphatase. The reaction was incubated 15 minutes at 37°C and then heat inactivated by
incubation for 5 minutes at 65°C.
The purified algF C194S fragment was ligated into digested, dephosphorylated pUC19
plasmid in a 20 µl overnight reaction at 16°C as follows: 4 µl purified algF C194S, 1 µl pUC19,
1 µl T4 DNA Ligase (New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 12
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µl Milli-Q water. Ligation reactions were transformed into Subcloning Efficiency™ DH5α™
Competent Cells (Invitrogen) as follows: 2.5 µl of ligation reaction was gently mixed into 50 µl
of DH5α cells that had been thawed on ice. Reaction was incubated on ice for 30 minutes and
then cells were heat shocked for 20 seconds in a 42°C water bath. Cells were returned to ice for
two minutes, 950 µl of Luria-Bertani media was added, and cells were allowed to recover for one
hour at 37°C with shaking. Cells were then plated on Luria-Bertani plates with ampicillin (100
µg/ml) and incubated overnight at 37°C. Resulting colonies were screened by the Quick-Check
method [57] and PCR to confirm the presence of the algF C194S insert. Successful ligation and
transformation for algF C194S in pUC19 resulted in plasmid pJP21 and E. coli strain JLP150.
To move the algF C194S fragment from pUC19 to pEX18Ap, a non-replicative plasmid
designed for use in Pseudomonas, plasmid pJP21 was isolated from strain JLP150 and digested
with BamHI-HF and EcoRI-HF high fidelity restriction enzymes from New England Biolabs.
Plasmid pEX18Ap was isolated from strain JLP148 and digested with these same restriction
enzymes in a standard double digest reaction. In brief, 4 µl NEB Buffer #4, 10 µl purified
pEX18Ap plasmid, 1 µl BamHI-HF, 1 µl EcoRI-HF, and 22 µl Milli-Q were incubated for one
hour at 37°C. An additional 1 µl BamHI-HF and 1 µl EcoRI-HF were added and the reaction
was incubated another hour at 37°C, for a total incubation time of two hours. The digestion
reactions were fractionated on a 1% agarose gel and the appropriate products were excised and
then purified using the QIAquick Gel Extraction Kit by Qiagen.
The purified algF C194S fragment was ligated into plasmid pEX18Ap in a standard 20 µl
overnight ligation reaction at 16°C using 1 µl of pEX18Ap and 8 µl of the insert. Subcloning
Efficiency™ DH5α™ Competent Cells (Invitrogen) were transformed with the ligation reaction
as outlined above. Resulting colonies were screened by PCR to confirm the presence of the algF

46

C194S insert. Successful ligation and transformation for algF C194S in pEX18Ap resulted in
plasmid pJP22 and E. coli strain JLP153.
To verify that the sequence encoding amino acid 194 in algF had been mutated from
TGC to TCC and that there were no other unintentional mutations in the coding sequence, strain
JLP153 was cultured overnight and plasmid pJP22 was purified for sequencing using the
QIAprep® Miniprep Kit (Qiagen). Sequencing was performed by Eurofins MWG Operon
(Huntsville, AL) and confirmed the presence of the engineered algF C194S mutation. Other
sequence differences identified did not result any change in amino acid sequence between the P.
aeruginosa FRD1 algF sequence and the published P. aeruginosa PAO1 sequence.
Transfer of the pEX18Ap plasmid construct into the P. aeruginosa ΔalgF strain
FRD1175 by conjugation was then attempted as follows. Cultures of FRD1175, JLP3
(containing the helper plasmid pRK2013), and JLP153 were started from individual colonies and
incubated in Luria-Bertani (LB) media, with antibiotics where appropriate, at 37°C with shaking.
After overnight incubation, 60 µl of the E. coli donor culture (JLP153) was sub-cultured into 3
ml of fresh LB media with 100 ug/ml ampicillin, and 60 µl of JLP3 (helper culture) was subcultured into 3 ml of fresh LB media supplemented with 30 µg/ml kanamycin. Both the donor
and the helper sub-cultures were incubated at 37°C with shaking for approximately five hours.
For the recipient FRD1ΔalgF strain FRD1175, one milliliter of overnight culture was combined
with one milliliter of fresh LB media and 40 µl of NaNO3 and incubated without aeration for
approximately 5 hours at 37°C. After incubation, 500 µl of the FRD1175 recipient strain, 600 µl
of the JLP3 helper strain, and 600 µl of the donor strain (JLP153) were combined and cells were
pelleted by centrifugation in a microcentrifuge at >13,000 rpm for three minutes. Supernatant
was removed, cells were washed with 500 µl of saline, and centrifuged again at >13,000 rpm for
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three minutes. Cells were then resuspended in 30 µl of saline, spotted on a Luria agar plate, and
incubated at 30°C. After overnight incubation, the cells were resuspended in three milliliters of
saline and varying dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and
Luria agar supplemented with 150 µg/ml of carbenicillin. Overnight incubation of the plates at
37°C failed to result in any conjugants.
Repeated attempts at conjugation of the pJP22 plasmid into P. aeruginosa using other
proven conjugation protocols and other P. aeruginosa strains also proved unsuccessful.
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Acetylation of Uronic Acids Produced by Alginate Biosynthesis Mutants

Evaluation of uronic acid recovery techniques
Before analysis of alginate production in various P. aeruginosa strains, it was necessary
to evaluate the available alginate recovery techniques currently in use. The FRD1 strain was
used as a positive control as it has been demonstrated to produce large amounts of alginate, and
the FRD2 strain, a non-mucoid revertant of FRD1caused by an algT mutation, served as a
negative control. Other strains that produced intermediate levels of alginate or polymer of
reduced length were analyzed to evaluate the effectiveness of the recovery techniques in these
situations.
Initial uronic acid assays were performed using total supernatant isolated by
centrifugation from overnight liquid cultures of P. aeruginosa FRD1, FRD2, and an algX mutant
strain which produces only a very minimal amount of alginate. While the supernatants from
FRD1 and the algX mutant strain performed adequately in the assay, the supernatant isolated
from the FRD2 culture resulted in a sample possessing a light brownish-peach color that
produced an interfering spectrophotometry reading.
The above strains were then grown as lawns on solid media overnight at 37°C. The
bacterial cells along with any alginate produced were harvested by dilution with saline and
manual scraping of the agar surface. Cells were pelleted by centrifugation and a portion of total
supernatant was used in the uronic acid assay. While this method of alginate recovery resulted in
appropriately colored samples for spectrophotometry, with little interfering color from the FRD2
negative control strain, the efficiency of bacterial cell removal by centrifugation was somewhat
reduced from that of broth cultures in strains producing large amounts of alginate.
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Another method sometimes used for the isolation of alginate from liquid cultures is
precipitation by cetylpyridinium. The procedure involves addition of 2% cetylpyridinium
chloride to supernatants, followed by centrifugation and an additional isopropanol precipitation.
Supernatants from cultures of the strains referenced above and an additional algG mutant strain
which produces small alginate fragments were subjected to cetylpyridinium precipitation and the
resulting re-suspended uronic acids were subjected to quantitation. While samples from the
FRD1 positive control strain and algX mutant strain possessed appropriate color and the FRD2
negative control strain did not possess interfering color, there was no reaction for the algG
mutant strain producing small alginate fragments. This indicated that the small uronic acid
fragments were not precipitated using this procedure.
Another precipitation method frequently used to isolate alginate is ethanol precipitation.
Supernatants from cultures of the same strains tested using cetylpyridinium precipitation were
subjected to ethanol precipitation using 2.5 volumes of 95% ice cold ethanol as outlined in the
Materials and Methods section on alginate isolation and the re-suspended precipitates were
assayed for uronic acid content. Samples from the FRD1 positive control strain and the
intermediate alginate producing algX mutant strain produced appropriate colors in the assay and
the FRD2 negative control strain sample did not produce any interfering color. The sample from
the algG mutant strain which produces small alginate fragments tested positive for uronic acid
indicating that the ethanol precipitation procedure successfully precipitated both polymer and
small uronic acid fragments. Given these results, ethanol precipitation from the supernatant of
liquid culture was selected as the standard protocol for isolation of uronic acid. Table 5
summarizes the characteristics of the evaluated alginate recovery techniques.

50

Table 5. Characteristics of alginate recovery techniques important to downstream applications
Alginate Recovery Technique

Component Used
in Assay

Interfering Color in
Negative Control

Isolation of
Small Uronics

Centrifugation of broth culture

Supernatant

Yes

Yes

Centrifugation of plate scrapes
diluted in saline

Supernatant

No

Yes

Cetylpyridinium precipitation of
broth culture supernatant

Precipitates
resuspended in
saline

No

No

Ethanol precipitation of broth
culture supernatant

Precipitates
resuspended in H2O

No

Yes
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Analysis of uronic acid acetylation in mutant strains
Over the last several years many alginate biosynthesis gene mutant strains have been
developed to study the effect of non-polar insertional mutations, deletions, or point mutations on
the production of alginate. While the level of alginate production from these strains has been
documented, the acetylation level of the alginate produced by these alginate biosynthesis mutants
has not been examined. The purpose of this work was to determine the acetylation status of the
alginate produced by these mutant strains and add to the current knowledge base regarding how
alginate polymerization and acetylation are related [12, 15, 22, 27, 51].
Seven alginate biosynthesis mutant strains were analyzed in this study, with this being the
initial analysis of alginate acetylation status by this method for six of the seven strains. Alginate
from two algG mutant strains, FRD1200, an algG deletion mutant producing small uronic acids
(<10,000 M.W.), and FRD462, a strain possessing a point mutation in algG and producing a
polymannuronate alginate lacking guluronates, were assayed for acetyl group content [14] [27].
The small uronic acids produced by the FRD1200 strain are believed to be products of alginate
degradation by the alginate lyase encoded by the algL gene [27]. The amount of acetyl groups
present in uronic acids from FRD1100, an algK deletion mutant demonstrating a non-mucoid
phenotype and producing low levels of dialyzable uronic acid, was also determined [27, 58] [12].
The remaining two published strains assayed were FRD1108 and FRD1144, an alg8 and an
alg44 non-polar insertional mutant, respectively, both possessing a non-mucoid phenotype and
negative for uronic acid production [22]. Uronic acids from an unpublished algX::Gm
insertional mutant strain were also analyzed. A similar construct was previously examined for
uronic acid production and the phenotypically non-mucoid strain was determined to produce low
levels of small uronic acids [15]. While the acetylation status of the alginate produced by
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FRD1175, an algF deletion mutant demonstrated to produce wild-type levels of non-acetylated
alginate, had been examined at the time the mutation was engineered, it was included in this
study as additional verification of assay results and for comparative purposes [59]. Levels of
uronic acid production and acetylation values for the mucoid CF strain FRD1 and its non-mucoid
revertant, FRD2, were also determined in the study for use as positive and negative controls,
respectively.
Uronic acids analyzed in this study were isolated by ethanol precipitation from overnight
Luria-Bertani broth cultures, and the uronic acid and acetylation levels were determined by
colormetric assays as outlined in the Materials and Methods section of this work. The results of
the uronic acid quantitation assay are presented in Figure 3.
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Figure 3. Levels of uronic acid produced by P. aeruginosa strains. Data are shown as mean
and standard deviation of a representative experiment carried out with technical triplicates.
Asterisks represent a significant change in amount of uronic acid produced by indicated strains
when compared to background levels found in the negative control strain FRD2 (P < 0.001, as
determined by Student’s t-Test).
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As expected, the FRD1 positive control strain produced significant levels of alginate as
determined by the assay. The algF and two algG mutants also produced measurable amounts of
uronic acid although not to the extent of that produced by FRD1. The level of uronic acid
produced by the alg8 mutant strain was the same as background levels detected in the FRD2
negative control strain. While the alg44 mutant strain showed a level of uronic acid production
that was determined to be significantly increased above the FRD2 background level, the overall
amount was extremely low. The algX and algK mutant strains, which both possess a nonmucoid phenotype, produced only low levels of uronic acids as measured in this assay.
Acetylation assay results are presented in Figure 4. The assay was performed on aliquots
of the same alginate solutions as used in the uronic acid assay.
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Figure 4. Levels of acetylation of uronic acids produced by P. aeruginosa strains. Data are
shown as mean and standard deviation of a representative experiment carried out with technical
triplicates. Uronic acid levels of all strains were normalized to FRD1 levels to allow for
comparison of acetylation levels between strains. Activity below that found in the FRD1175
algF mutant strain, previously determined to produce un-acetylated polymer, was treated as
background activity.
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Of the strains assayed, only the FRD1 positive control strain and the algG mutant strain
FRD462 that had been shown to produce a polymannuronate polymer produced uronic acids that
possessed levels of acetyl groups above background levels. As the non-mucoid FRD2 strain and
the alg8 mutant strain FRD1108 did not produce levels of uronic acid over background, any level
of acetylation detected by the assay for these samples would be background activity only. The
other strains assayed, with mutations in algX, algG (FRD1200), and algK (FRD1100), did not
produce uronic acids containing amounts of acetyl groups above the background levels found in
the algF (FRD1175) acetylation-deficient strain.
The findings from both assays are summarized in Table 6.
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Table 6. Characteristics of select P. aeruginosa alginate biosynthesis mutant strains relating to
uronic acid production
Strain

Mutation and
affected Gene

Gene
Function

Phenotype

Uronic Acid
Production

Uronic Acid
Acetylation

FRD1175

ΔalgF

Acetylation

Mucoid

Full-length
polymer

No

FRD1200

ΔalgG

Epimerization,
Scaffold

Non-mucoid

Small uronic acids

No

FRD462

Point mutation
algG4

Epimerization,
Scaffold

Mucoid

Full-length
polymannuronate
polymer

Yes

FRD1100

ΔalgK

Scaffold

Non-mucoid

Small uronic acids

No

FRD1108

alg8::Gm

Polymerization

Non-mucoid

None

N/A

FRD1144

alg44::Gm

Polymerization

Non-mucoid

None

N/A

JLP4

algX::Gm

Unknown

Non-mucoid

Small uronic acids

No
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Discussion
Based on the results of the acetylation assays of the P. aeruginosa alginate biosynthesis
mutant strains studied in this work, and on information gathered from previous studies of the
alginate produced by these strains, it can be concluded that the small, dialyzable uronic acids
produced by the algX, algG, and algK alginate biosynthesis mutant strains are not acetylated.
The algX, algG, and algK mutant strains produced different amounts of small uronic acids, but in
all cases the amount of acetyl groups per microgram of uronic acid present in the sample was
below background levels. The lack of acetylation of the small uronic acids produced by the algX
mutant strain in this study is in agreement with findings from the mass spectrometry analysis of
the small oligouronides produced by a similar algX mutant strain in the work published by
Robles-Price [15].
This observation has important implications regarding the localization of the acetylation
step in the formation of full-length, acetylated alginate polymer. The lack of acetylation of small
uronic acid fragments suggests that a polymer of some minimum length is necessary for
acetylation to take place, supporting the hypothesis that alginate acetylation takes place in the
periplasm and not in the cytoplasm where only non-polymerized, individual mannuronates would
be present.
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Involvement of the algX Alginate Biosynthesis Gene in Alginate Acetylation

Confirmation of the non-polarity of an algX::Gm mutation
The alginate biosynthesis gene algX shares 30% identity with the alginate acetylation
gene algJ, and has thus been postulated to play a role in the alginate acetylation process. A
strain bearing a non-polar algXΔ::Gm mutation was shown to be deficient in alginate polymer
formation, producing and secreting small uronic acids instead, and suggesting a role in scaffold
formation and not acetylation [15]. However, if the algX gene product plays a role in both
acetylation and scaffold formation, a mutation of this type could obscure any effect of AlgX on
acetylation. An alternative strategy that could preserve the ability of AlgX to function in the
scaffold and yet reveal any involvement in acetylation was developed based on the homology
between the algX and algJ genes. A histidine to alanine point mutation of amino acid 195 within
a conserved motif present in AlgJ was shown to produce non-acetylated alginate when expressed
in trans in an algJ deletion strain [60]. This same conserved motif is present in AlgX with the
histidine residue located at position 176 (Figure 5).
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Figure 5. Partial protein sequence alignment of P. aeruginosa AlgJ and AlgX showing the
conserved motif present in a subset of type II membrane proteins. Amino acids highlighted
in gray indicate conserved residues within the subset. Positions are indicated above key residues.
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195

AlgJ

LAVIPAKA-------RTDTHWSPLG

AlgX

VVYQPTRG-------KGDHHWTPHG
113

176
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If AlgX is involved in alginate acetylation, the same mutation of this conserved histidine
residue in AlgX may abolish acetylation but allow for production of alginate by preserving
AlgX’s function within the scaffold. An algX::Gm mutant strain, designated JLP4, was
previously created in the Ohman lab, however, before it could be used in this study it was
necessary to confirm that the gentamicin cassette insertion into algX was non-polar and that loss
of the mucoid phenotype was not due to deleterious effects on downstream genes. This was
accomplished by providing algX in trans on plasmid pMF54 in the algX::Gm mutant strain and
verifying restoration of the mucoid phenotype and production of acetylated alginate. Generation
of this algX::Gm complementation strain, JLP121, was accomplished as outline in the Materials
and Methods section.
Overnight growth of P. aeruginosa strain JLP121 [FRD1algX::Gm(pJP12)] on LuriaBertani agar at 37°C resulted in colonies with a mucoid phenotype typical of the FRD1 parent
strain. Alginate was isolated from strain JLP121 and subjected to uronic acid and acetylation
quantitation as outlined in the Materials and Methods section. Results from the uronic acid and
acetylation assays indicated no significant differences in alginate production or acetylation for P.
aeruginosa JLP121 and FRD1 strains. The ability of only AlgX provided in trans to complement
the algX::Gm insertional mutant indicated that the mutation did not exert negative effects on
downstream genes and would be suitable for further investigation into the role of AlgX in
acetylation (Figures 6 and 7).
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Figure 6. Levels of uronic acid produced by P. aeruginosa strains FRD1 and algX
complementation strain JLP121. Data are shown as mean and standard deviation of three
separate experiments. There was no significant difference between the strains in amount of
alginate produced (P < 0.001, as determined by Student’s t-Test).
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Figure 7. Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 and
algX complementation strain JLP121. Data are shown as mean and standard deviation for
three separate experiments. There was no significant difference between the strains in acetyl
groups per milligram of uronic acids for alginate produced (P < 0.001, as determined by
Student’s t-Test).
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Effect on acetylation of a mutation of a conserved amino acid in algX
To determine whether or not AlgX is involved in alginate acetylation in addition to its
role as a scaffold protein, a site-directed mutation was made in the DNA sequence of the algX
gene. The mutation changed a conserved histidine residue at position 176 of the AlgX protein
sequence to an alanine. This histidine residue is conserved in alginate acetylation protein AlgJ
and other type II membrane proteins, as well as in AlgX which shares 30% identity with AlgJ.
When this same mutation in AlgJ was expressed in trans from a plasmid in an algJ deletion
strain it resulted in loss of alginate acetylation [60]. In order to test the effect of this mutation in
AlgX on alginate acetylation, a plasmid expressing algX H176A was introduced into an
algX::Gm strain as described in the Materials and Methods section, creating strain JLP135
(Figure 8).
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Figure 8. Schematic representation of alginate biosynthesis algX gene H176A site-directed
mutation and replicative plasmid pMF54. Overlapping extension polymerase chain reaction
was used to mutate two nucleotides, changing the codon at position 176 from CAC (histidine) to
GCC (alanine). Stabilizing fragment (S.F.) is required for replication of the plasmid in P. aeruginosa
and oriT is required for conjugation into Pseudomonas.
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Overnight growth of this strain on Luria-Bertani agar at 37°C resulted in mucoid colonies
indicating that the mutation did not disrupt alginate production. The phenotype of this strain was
indistinguishable from that of strain JLP121 expressing wild-type algX from the same plasmid in
the algX::Gm strain (Figure 9).
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Figure 9. P. aeruginosa FRD1, JLP4, JLP121, and JLP135 strains after overnight growth
on Luria-Bertani agar at 37°C. Strains FRD1, JLP121, and JLP135 exhibit a mucoid
phenotype while strain JLP4 does not.
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To verify alginate production and determine its level of acetylation, alginate was isolated
from strain JLP135 and subjected to uronic acid and acetylation quantitation as outlined in the
Materials and Methods section. Results from the uronic acid and acetylation assays indicated no
significant differences in alginate production or acetylation for P. aeruginosa JLP135 and
JLP121, the strain expressing wild-type algX from plasmid pMF54 (Figures 10 and 11).
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Figure 10. Levels of uronic acid produced by P. aeruginosa strains JLP121 and algX
H176A mutation strain JLP135. Data are shown as mean and standard deviation of three
separate experiments. There was no significant difference between the strains in amount of
alginate produced (P < 0.001, as determined by Student’s t-Test).
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Figure 11. Levels of acetylation of uronic acids produced by P. aeruginosa strain JLP121
and algX H176A mutation strain JLP135. Data are shown as mean and standard deviation for
three separate experiments. There was no significant difference between the strains in acetyl
groups per milligram of uronic acids for alginate produced (P < 0.001, as determined by
Student’s t-Test).
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Discussion
The availability of the FRD1algX::Gm strain will facilitate further study of the role AlgX
may play in alginate biosynthesis. While this study indicates that AlgX is not involved in
acetylation, it is possible that the histidine residue, while conserved between AlgX and AlgJ, is
not a key residue for the function of AlgX. The difference in amino acid sequence between the
two indicates a different role for AlgX, and whether involved in acetylation or not, residues
necessary for activity may lie elsewhere in the protein. It is also possible that the neighboring
histidine residue in algX (residue 175), not present in algJ, is able to compensate for the mutation
of histidine 176 to an alanine. Mutation of both residue 175 and 176 may be necessary to see an
effect. An avenue that might provide additional information about AlgX would be random
mutagenesis of the algX coding region. This may generate mutants with interesting phenotypes
that could be further explored.
Aside from the obvious data garnered from these results, the sequencing of the algX gene
provided more subtle insight into the sequence of FRD1. The number of base pair differences
between the sequence of algX and the published sequence for PAO1 emphasizes the possible
differences between the two strains at a sequence level, aside from the mutations that are already
known. And while three of the four differences discovered within the algX sequence did not
result in a difference at the amino acid level, it has been demonstrated that even silent mutations
can have a significant effect on transcription and translation [61].
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Transcriptional Analysis of the Alginate Biosynthesis Operon

Effect of culture media on acetylation of alginate produced by FRD1
Previous studies on both P. aeruginosa and the alginate-producing soil bacterium
Azotobacter vinelandii have shown that levels of alginate acetylation in an individual strain can
be influenced by changes in culture media. For A. vinelandii, the addition of the buffering agent
3-(N-morpholino)-propane-sulfonic acid (MOPS) to the growth culture at a concentration of 13.6
mM increased the amount of alginate acetylation two-fold over that for the same strain cultured
without the addition of MOPS. The mean molecular masses and guluronate to mannuronate
ratios for the alginate isolated from these cultures remained the same [62]. In work by Marty et
al. [63], alginates produced by a mucoid P. aeruginosa strain isolated from a cystic fibrosis
patient grown on solid nutrient media of various types were analyzed. The alginate isolated from
this mucoid strain grown on Modified Alginate Promoting (M.A.P.) media showed an increased
level of acetylation when compared to the acetylation level of the alginate isolated from the same
strain grown on MacConkey media. There was no statistically significant change in the percent
of alginate produced by the strain when grown on the different media or in the guluronate to
mannuronate ratio [63]. While these findings demonstrated an ability to alter the level of
alginate acetylation, the mechanism by which it is accomplished was not further investigated.
To determine whether similar growth conditions would influence the acetylation levels of
the mucoid P. aeruginosa strain FRD1, uronic acid and acetylation amounts were measured for
alginates produced from the strain when grown in culture media supplemented with MOPS, and
when grown in M.A.P. and MacConkey broths. As the work by Pena showed that the percent of
alginate acetylation increased with increasing concentrations of MOPS (0 mM to 13.6 mM), the
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highest concentration was selected for use in the analysis of FRD1 alginates [62]. Alginate was
isolated by ethanol precipitation from FRD1 cultures grown overnight in Luria-Bertani media
and Luria-Bertani media supplemented with MOPS to a concentration of 13.6 mM. Uronic acid
assays for alginate quantitation were performed using a method based on that of Dische [55] and
acetylation amounts (microgram of acetyl group per milligram of uronic acid) were determined
according to the method described by Hestrin [56]. The assays showed that while the total
amount of uronic acid produced was significantly reduced for FRD1 grown in media containing
MOPS (Figure 12), the acetylation level of the alginate produced was significantly increased by
the addition of MOPS to the culture media (Figure 13). This increase in alginate acetylation was
similar to that seen in the A. vinelandii strain.
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Figure 12. Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in
un-supplemented Luria-Bertani culture media and in Luria-Bertani media supplemented
with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS). Data are shown as mean
and standard deviation for two separate experiments with triplicates. Asterisk represents a
significant decrease in micrograms uronic acid per milligram of cell pellet produced by FRD1
when grown in Luria-Bertani media supplemented with MOPS (P < 0.001, as determined by
Student’s t-Test).

84

30

ug Uronic Acid/mg Cell Pellet

P < 0.001

25
20

*
15
FRD1
10
5
0

No MOPS

MOPS

Growth Media

85

Figure 13. Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1
when grown in un-supplemented Luria-Bertani culture media and in Luria-Bertani media
supplemented with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS). Data are
shown as mean and standard deviation for two separate experiments with triplicates. Asterisk
represents a significant increase in acetyl groups per milligram of uronic acids for alginate
produced by FRD1 when grown in Luria-Bertani media supplemented with MOPS (P < 0.001, as
determined by Student’s t-Test).
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To assess the effect on alginate acetylation of growth of P. aeruginosa FRD1 in different
nutrient media, bacterial cultures were grown overnight in Modified Alginate Promoting
(M.A.P.) broth and MacConkey broth. Alginates were isolated by ethanol precipitation and
uronic acid (Figure 14) and acetylation levels (Figure 15) were measured by the methods
referenced earlier. In accordance with the data presented by Marty et al. [63], the alginate
produced by P. aeruginosa FRD1 grown in M.A.P. media was significantly more acetylated than
that produced by the same strain grown in MacConkey media (Figure 15). There was no
significant difference in the levels of alginate produced by the strain when grown in MacConkey
and M.A.P. media (Figure 14).
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Figure 14. Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in
MacConkey and Modified Alginate Producing (M.A.P.) culture media. Data are shown as
mean and standard deviation for three separate experiments. There was no significant change in
levels of uronic acids produced by FRD1 when grown in MacConkey or M.A.P. media (P <
0.001, as determined by Student’s t-Test).
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Figure 15. Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1
when grown in MacConkey and Modified Alginate Promoting (M.A.P.) culture media.
Data are shown as mean and standard deviation for three separate experiments. Asterisk
represents a significant increase in acetyl groups per milligram of uronic acids for alginate
produced by FRD1 when grown in M.A.P. media (P < 0.001, as determined by Student’s t-Test).
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Sequence analysis of upstream regions of alginate biosynthesis genes
Having demonstrated the ability of the P. aeruginosa FRD1 strain to vary the level of
alginate acetylation in response to growth media, experiments were undertaken to investigate a
possible transcriptional basis for this finding. Given the similarities between the A. vinelandii
alginate biosynthesis operon and that of P. aeruginosa, and the presence of promoters upstream
of the A. vinelandii algG and algA genes [44], a sequence analysis of the upstream regions of
select P. aeruginosa alginate biosynthesis genes was done. Upstream regions for algG, algX,
algL, algI, algJ, algF, and algA were analyzed using BPROM analysis software, a sigma 70
bacterial promoter recognition program [64]. For genes where the upstream intergenic region
was larger than 100 base pairs, the entire intergenic region was analyzed. For genes with smaller
upstream intergenic regions, a 100 bp upstream region was analyzed, possibly containing the
downstream region of the preceding gene. Upon analysis, none of the upstream regions
reviewed produced any potential sigma 70 binding sites. The sequences of these same upstream
regions were then manually scanned for possible consensus sequences for sigma factors E (AlgU
or AlgT) and 54 (RpoN), both have which been shown to be involved in the regulation of
alginate production [41]. This sequence scan produced a potential consensus match for σ54 in the
upstream region of the algX biosynthesis gene (Figure 16).
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Figure 16. Upstream region (100 nt) of P. aeruginosa alginate biosynthesis gene algX with
potential -12 and -24 consensus regions highlighted in gray. The regions are a match for the 12 and -24 regions recognized by σ54 [-24(GGA)/-12(GC)]. The algX start codon is indicated by
a gray box.
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Potential -12 and -24 consensus regions

-24

-12

--------GACCAGATCCTCGACCTGCTGGTGCGCCAGGACAAGGCGGTGCTGATCGACCCCGTGGAA
AGCCAGGCCGAACTCCAGGACTGAGGACCCAGACGCATG--------

P. aeruginosa algX start codon
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While the work by Vazquez which identified the presence of a promoter upstream of the
A. vinelandii algG alginate biosynthesis gene and the corresponding mRNA start site did not
identify a consensus sequence match to any known promoters, the approximate -10 and -35
regions were found to match those of the A. vinelandii algR promoter region [44]. An alignment
of the A. vinelandii and P. aeruginosa algG upstream regions identified a similar consensus
sequence upstream of the P. aeruginosa algG gene within the coding region of algE (Figure 17).
Further investigation into the other biosynthesis gene upstream regions identified a
similar consensus sequence upstream of the P. aeruginosa algI biosynthesis gene (Figure 18).
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Figure 17. Sequence alignment of the upstream regions of the alginate biosynthesis gene
algG from P. aeruginosa and A. vinelandii. Consensus in the -10 and -35 regions is
highlighted in light gray and asterisks indicate exact nucleotide matches. Alignment was done
using ClustalW [65].
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A. vinelandii mRNA start site

-35
A. vinelandii
AZOTO
----------------------------------------TGCACCGTGTCTTCGTCGAC
P. aeruginosa
PSEUDO
AAGCCGGGCGACGCCTACGGGCCGGGCACCGACTCGACCATGCACCGCGCCTTCGTCGAC

******* * **********
-10
A. vinelandii
AZOTO
ATGATCTGGCGCTTCTAAGGTCCAGCGGCACGCTGAGAGGATCGAACATGAACGTGCAAA
P. aeruginosa
PSEUDO
TTCATCTGGCGCTTCTGAGCCCCG---------CGAGGAAACCGGACATG----------

* *************
* *************
** ** ** **
*** * ** ********
* ************* **

**

* ************* **

**

algE stop codon for P. aeruginosa

* ** *****

algG start codon for P. aeruginosa
and A. vinelandii
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Figure 18. Upstream region (240 nt) of P. aeruginosa alginate biosynthesis gene algI with
potential -10 and -35 consensus regions highlighted in gray. The regions are a partial match
for the -10 and -35 regions found within the A. vinelandii algR promoter. The algI start codon is
indicated by a gray box.
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Potential -10 and -35 consensus regions

-35

-10

--------GGCGTGGCGGGAAGCGGGCGCACAGGCCGGGGGCCACGCGCCCCTCTACCCCGCTCGCCGACCAGGCGT
CCCACCAGGCGCCACACCCCGACCCATGCGCGACAGACGCGGGCGGGCGCAACACCTTAGGCAACACCACGGGGAGG
AAAACGGCGGGTCGTCCCGCCTTTCCTCGAGCGCTCCAGGGCGCGGAAAGGCAGGGCCGACCTGAATGGTTGACGCT
CTAGAGAGAGAGACGGCATG--------

P. aeruginosa algI start codon

DNA sequence at -10 and -35 of A. vinelandii algR promoter region – CCGTGN23-CGCT
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Demonstration of promoter activity in regions upstream of algG and algI alginate
biosynthesis genes
To further investigate transcriptional activity within the alginate biosynthesis operon and
assess potential promoter activity, beta-galactosidase assays were performed with the upstream
regions of several genes within the operon. LacZ fusion plasmids were constructed using
plasmid pSS269 (medium copy vector) containing the upstream regions of algG, algX, algI, algJ
and algF and conjugated into P. aeruginosa strain FRD1 (Figure 19).
The beta-galactosidase activity induced by these upstream regions was compared to
baseline endogenous activity in the P. aeruginosa FRD1 strain. In addition, the activity of the
PalgD promoter was assayed as a positive control for the experiment and for comparative value.
Of the regions assayed, algG and algI were found to possess significant activity while algX, algJ,
and algF did not. The strain containing the upstream region of algG demonstrated
approximately 30% of the activity possessed by the strain containing the upstream region of algI,
with both expressing significantly less activity than the PalgD control strain. Activity measured
for the strains containing the upstream regions of algX, algJ, and algF was at or below the
baseline level for the FRD1 strain (Table 7).
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Figure 19. Schematic representation of alginate biosynthesis gene upstream regions and
lacZ reporter plasmid pSS269 listing the strain generated by each fusion. Overhangs
generated by annealing of complimentary single-stranded oligonucleotides or by digestion of
PCR product with restriction enzymes are shown. Stabilizing fragment (S.F.) is required for
replication of the plasmid in P. aeruginosa and oriT is required for conjugation into
Pseudomonas.
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Upstream Region
5’ aatt
5’ aatt
5’ aatt

5’ aatt

Fusion Strain

100bp

ctag

algG

JLP159

100bp

ctag

algX

JLP170

ctag

algJ

JLP167

ctag

algF

JLP165

ctag

algI

JLP162

100bp

5’ aatt

Alginate Biosynthesis Gene

100bp

250bp

EcoRI SmaI BamHI
Pstl

SF
Pstl

lacZ

β-lactamase

pSS269

HindIII

oriT
HindIII
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Table 7. Beta-galactosidase activity of lacZ fusion contructs containing upstream regions of
alginate biosynthesis genes in FRD1

a

Activity

Significanta
(P<0.001)

Strain

Region

Miller Units
(Average)

FRD1

N/A

14.2 ± 2.1

No

No

JLP173

algG upstream

53.9 ± 10.2

Yes

Yes

JLP184

algX upstream

4.6 ± 4.4

No

No

JLP176

algI upstream

195.9 ± 28.4

Yes

Yes

JLP179

algJ upstream

12.8 ± 3.2

No

No

JLP182

algF upstream

4.9 ± 3.3

No

No

JLP196

PalgD

84083 ± 17536.8

Yes

Yes

Represents a significant increase in beta-galactosidase activity as compared to the FRD1 strain.
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Attempted identification of mRNA start sites in regions upstream of algG and algI alginate
biosynthesis genes
In an effort to determine mRNA start sites for the promoters identified through the betagalactosidase assay, 5’ RACE was attempted for the upstream regions of the algG and algI
alginate biosynthesis genes. Using the SMARTer™ Race kit by Clontech, 5’ RACE ready
cDNA containing modified 5’ ends was generated for each upstream region using gene specific
primers. Successful generation of the cDNA was confirmed by amplification of prepared control
cDNA using test primers included in the kit, and successful binding of the gene specific primers
was confirmed by amplification of cDNA fragments using both the forward and reverse real-time
primers for each gene. Multiple attempts at PCR amplification of cDNA fragments containing
the 5’ end, however, proved unsuccessful. A product of approximately 500 bp was amplified
from the algI cDNA during a PCR reaction designed to amplify transcript originating from the
algD promoter, but cloning and subsequent sequencing did not yield sequence matching the
upstream region of algI.

Evaluation of relative transcript levels of alginate biosynthesis genes from FRD1 grown in
Luria-Bertani, MacConkey and Modified Alginate Promoting media
To gather further information about the mechanism by which alginate acetylation levels
are modified within P. aeruginosa, real-time PCR was performed to evaluate transcript levels of
select genes within the biosynthesis operon. Transcript levels of algD, algG, algI and algA
produced from P. aeruginosa strain FRD1 were measured when grown under similar conditions
but in different media types. Transcript levels of oprF, an outer membrane protein, were also
measured and used for normalization. MacConkey and Modified Alginate Promoting media
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(M.A.P.) were used since FRD1 grown in these media types was shown previously to produce
alginate with different levels of acetylation (this study). Transcript levels from P. aeruginosa
FRD1 grown in Luria-Bertani were also measured as this is often the standard culture media.
RNA was isolated from FRD1 cultures grown in the various media types as outlined in
the Materials and Methods section and relative transcript levels were obtained by quantitative
real-time PCR. Under typical growth conditions in Luria-Bertani media, normalized transcript
levels of algG, approximately 5.8 kb downstream of algD, decreased sharply compared to algD.
Interestingly, normalized transcript levels of algI, approximately 10.2 kb downstream of algD
and 2.8 kb downstream of algG, were measured at levels below those of algD, but significantly
above those of algG. Normalized transcript levels of algA, 2.1 kb downstream of algI, were
decreased from levels of algI, but significantly above those of algG (Figure 20).
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Figure 20. Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa
strain FRD1 grown in Luria-Bertani media. Data are shown as mean and standard deviation
for two separate experiments carried out with technical triplicates.
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Compared to relative transcript levels from P. aeruginosa grown in MacConkey media,
transcript levels were significantly increased for all studied genes from P. aeruginosa grown in
M.A.P. media, with the exception of algG. As in FRD1 cultures grown in Luria-Bertani media,
transcript levels of algG were significantly decreased compared to other studied genes within the
alginate biosynthesis operon and levels were not significantly different between growth in
MacConkey and M.A.P. media types. Unlike transcript levels for algA from P. aeruginosa
grown in Luria-Bertani or MacConkey media, transcript levels of algA tended to increase over
levels of algI from P. aeruginosa grown in M.A.P. media (Figure 21). The fold increase of
transcript levels measured from FRD1 M.A.P. cultures over those measured from MacConkey
cultures was similar for algD and algI, and somewhat less for algG. The fold increase in algA
transcript levels was the highest of the four studied biosynthesis genes (Table 8).
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Table 8. Fold increase in normalized transcript levels of alginate
biosynthesis genes in P. aeruginosa strain FRD1 grown in M.A.P. media
over those grown in MacConkey media
Gene

Fold Difference

algD

1.7

algG

1.4

algI

1.8

algA

2.5
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Figure 21. Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa
strain FRD1 grown in MacConkey media and Modified Alginate Promoting (M.A.P.)
media. Data are shown as mean and standard deviation of a representative experiment carried
out with technical triplicates. Asterisks represent a significant increase in gene transcript
amounts in FRD1 grown in M.A.P. media over those in FRD1 grown in MacConkey media (P <
0.01, as determined by Student’s t-Test).
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Discussion
The data presented here clearly identify the presence of two previously unknown
promoters within the alginate biosynthesis gene cluster. The results of the beta-galactosidase
assays indicate one promoter within the region 100 nucleotides upstream of the algG gene,
possibly within the algE coding region, and another within the 250 nt region upstream of the algI
coding region (Table 7). In the mucoid P. aeruginosa FRD1 strain under typical laboratory
growth conditions, the activity of the promoter upstream of the algI gene as measured by the
level of enzyme activity from the reporter fusion plasmid appears approximately 60% more
active than the promoter upstream of the algG gene. While in both cases sequence scans of the
promoter-containing regions did not reveal a sequence match to any known promoter consensus
sequence, both regions did contain sequence similar to that found at the -10 and -35 regions of
the promoter region of the A. vinelandii algR gene (Figures 17 and 18). This sequence is also
found in the -10 and -35 regions of the previously identified promoter upstream of the algG gene
in A. vinelandii (Figure 15). Further analysis also identified an exact match for this sequence in
the promoter region of the P. aeruginosa algR gene (Figure 22). As transcription of the A.
vinelandii algR gene is not regulated by sigma 22 (AlgU/AlgT) or AlgR as it is in P. aeruginosa,
both algR and algG in A. vinelandii are believed to be regulated by a sigma factor that has not
yet been identified [44, 66]. It is possible that a similar unidentified sigma factor may be
responsible for transcription from these newly identified promoters upstream of the algG and
algI alginate biosynthesis genes in P. aeruginosa. Previous work has shown that a transposon
insertion into the algD gene, the first gene in the alginate biosynthesis gene cluster, has a polar
effect on downstream genes to the extent that a non-mucoid phenotype results and transcription
of downstream genes, including algA, is reduced [51]. While this would indicate that any
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promoters present within the alginate biosynthesis gene cluster lack sufficient activity to produce
a mucoid phenotype on their own, it does not rule out the possibility that other promoters within
the cluster may exist and possess sufficient activity to alter polymer characteristics.
A model of the alginate biosynthesis operon illustrating the newly discovered promoter
sites is shown in Figure 23.
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Figure 22. Upstream region (130 nt) of P. aeruginosa alginate biosynthesis transcriptional
regulator gene algR with key areas indicated. Underlined sequence is similar to sigma E
(AlgU/AlgT/RpoE/sigma 22) promoter consensus sequence and overlined sequence matches
sigma 54 promoter consensus sequence. Gray shaded sequence matches -10 and -35 region
sequence of algR from A. vinelandii. The mRNA start site (+1), the putative ribosome-binding
site, and the algR start codon are indicated.

115

+1

-----CACAATATCGATGCACGACTTGGGGCACTTTTCGGGCCTAAAGCGAGTCTCAGCGTCGAGCGCCGTGACGGA
CGGCACTACACCTGTCTACGCTATCCATGTGCGCGACTCATGCAGGAAGCCTGAGCTTATGAATGTCCT----Putative RBS
P. aeruginosa algR start codon
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Figure 23. Model of P. aeruginosa alginate biosynthesis operon showing the PalgG and PalgI
promoter sites.
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The promoter identified upstream of algI in this work may function in this manner,
contributing to the increase in transcript levels of algI and the downstream algA gene for P.
aeruginosa FRD1 grown in M.A.P. media demonstrated by the qRT-PCR results (Figure 19). As
hypothesized, levels of algI transcript from FRD1 grown in M.A.P. media were increased over
levels of algI transcript from FRD1 grown in MacConkey media. However, the increase in
transcript level of algI was not sufficient when compared to the increased transcript level of algD
to rule out transcription from the algD promoter as the cause for the increased level of algI
transcript. Growth in M.A.P. media is known to increase the level of alginate production of
mucoid P. aeruginosa strains [67], and while the increase in algD transcription was expected, the
decreased level of transcript from the algG gene upstream of algI complicates the comparison of
transcript levels between algI and algD. Of note, however, is the observation that the transcript
level of the algA gene was increased over the transcript level of algI for FRD1 grown in M.A.P.
media, but not for FRD1 grown in either Luria-Bertani or MacConkey media, lending support to
the hypothesis of differential regulation (Table 8). It is not known whether the effect of
increased alginate acetylation for strains grown in M.A.P media or with the addition of MOPS to
the growth media is due to the chemical composition of the media or possibly an increased
buffering capacity.
Another significant finding of this work resulted from the quantitative real-time PCR
analysis of select alginate biosynthesis genes. Data showed that regardless of the growth media,
transcript levels of the FRD1 algG gene were significantly less than transcript levels of the algD
and algI genes (Figures 20 and 21). As the algG gene is located approximately 5.8 kb
downstream of the PalgD promoter, it is not surprising that transcription of the gene may be
affected by ‘natural polarity’ as is the case for some other genes located distal to the promoter in
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large operons [68]. The relative increase in transcript levels of algI compared to algG may be
attributed to transcription from yet unidentified sigma 22 binding sites downstream of algG,
transcription from the promoter upstream of algI identified in this work, or some combination of
these mechanisms.
From a functional standpoint, the reduced level of algG transcripts demonstrated by the
quantitative real-time PCR analysis is not surprising. In both P. aeruginosa and A. vinelandii the
algG gene encodes a C-5 epimerase for epimerization of mannuronates into guluronates.
However, A. vinelandii also possesses an additional seven extracellular epimerases that can
generate different patterns of mannuronates and guluronates in the alginate polymer, as well as
blocks of guluronates of varying length [69]. These additional epimerases in A. vinelandii are
necessary to generate a polymer containing sufficient guluronates for the cyst formation
characteristic of the bacteria. An engineered strain of A. vinelandii possessing only the
epimerase encoded by the algG gene, produced an alginate polymer consisting of only 2%
guluronate residues where the wild-type strain produced a polymer of 25% guluronnate [70]. As
P. aeruginosa does not undergo an encystment process and does not possess any additional
mannuronate epimerases, the level of mannuronate epimerization generated by the algG gene
product is evidently sufficient for the bacteria’s needs [71]. In addition, the algL gene in P.
aeruginosa, found downstream of algG and upstream of algI, encodes an alginate lyase which
has been shown to be deleterious to the alginate produced by strains overexpressing this gene
product [72].
Further transcriptional studies would be extremely helpful in formulating a hypothesis
regarding transcriptional activity and possible differential regulation within the biosynthesis
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operon. Quantitative RT-PCR on the remaining biosynthesis genes would provide additional
clarification as would beta-galactosidase assays.
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Involvement of Disulfide Bonding in AlgF Protein Interactions

Generation of recombinant AlgF protein and detection of interacting proteins
As much of the genetic analysis on the P. aeruginosa alginate biosynthesis operon
supports the hypothesis of a scaffolding complex necessary for the production of alginate
polymer, an investigation into protein interactions involving the acetylation protein AlgF was
initiated. To facilitate this analysis, a strategy for the construction, expression, and purification
of a Strep-II tagged AlgF recombinant protein was developed. The Strep-tag II/Strep-Tactin
system had previously been used successfully in protein co-purification experiments involving
another alginate biosynthesis protein, AlgX, and was selected for use in this analysis [73].
The pASK-IBA63b vector was purchased from IBA GmbH (Goettingen, Germany) and
modified for use in P. aeruginosa as illustrated in Figure 24 and as outlined in the Materials and
Methods section. The coding sequence of algF from P. aeruginosa strain FRD1 was inserted
into the multiple cloning site (MCS) of the modified vector and the resulting plasmid was
conjugated into the ΔalgF strain FRD1175 resulting in strain JLP113.
Growth curves of the three P. aeruginosa strains FRD1, FRD1175, and JLP113 were
generated to determine if expression of the Strep-II tagged AlgF protein in JLP113 negatively
affected the strain’s growth (Figure 25). In conjunction with the time points of the growth
curves, cell lysates were collected and subjected to SDS-PAGE and immunoblotting (Figure 26).
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Figure 24. Schematic representation of commercial C-terminal Strep-II tag® vector
pASK-IBA63b altered for use in P. aeruginosa. Pseudomonas oriT was incorporated into an
SpeI restriction site to allow for conjugation into P. aeruginosa and mSF was incorporated at an
NaeI site to allow for replication in Pseudomonas.
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Figure 25. Growth curves of P. aeruginosa strains FRD1 (CF isolate), FRD1175
(FRD1ΔalgF), and JLP113 (FRD1175 with AlgF-Strep-II tag). Strains were grown in LuriaBertani broth with shaking at 37°C. Data are shown as mean and standard deviation for three
separate experiments.
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Figure 26. Immunoblot showing AlgF expression in FRD1, FRD1175, and JLP113 across a
time course. Whole cell lysate from each strain was screened using α-AlgF antibody.
Expression of AlgF in FRD1 increases somewhat over time while expression of recombinant
AlgF in JLP113 decreases with time after induction. Amount of protein per lane was
standardized to total protein for each time point.
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Similarities of the growth curves indicated that the expression of the tagged AlgF protein
in P. aeruginosa algF deletion strain JLP113 did not have a deleterious effect on the growth of
the bacteria. The immunoblot of cell lysates collected over the growth course showed that in the
FRD1 strain levels of wild-type AlgF increased over time in relation to total protein. Expression
of the plasmid-encoded Strep-II tagged AlgF in JLP113 appeared to follow an opposite pattern
with the amount of AlgF protein decreasing with the progression of time. As expected, strain
FRD1175 did not produce any AlgF over the time course.
To determine whether the AlgF Strep-II tagged protein was able to complement the algF
deletion mutant in regard to alginate acetylation, alginate was isolated from each of the strains
and the uronic acid and acetyl group content was determined. As indicated by the results of the
uronic acid assay, there was no significant difference in the amount of alginate produced by the
strains (Figure 27). Results of the acetylation assay indicated that the level of acetylation for the
alginate produced by the strain complemented with the AlgF-tagged protein was significantly
below that of the alginate produced by the FRD1 strain. Even at this reduced level, however,
acetylation levels in the complemented strain were still increased significantly over background
levels indicating at least a minimal level of restoration of acetylation (Figure 28).
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Figure 27. Levels of uronic acid produced by P. aeruginosa strains FRD1, FRD1175, and
JLP113. Data are shown as mean and standard deviation of three separate experiments. There
was no significant difference between the strains in amount of alginate produced (P < 0.001, as
determined by Student’s t-Test).

130

80

ug Uronic Acid/mg Cell Pellet

P<0.001

70
60
50

40
30
20

10
0

FRD1

FRD1175
Strain

JLP113

131

Figure 28. Levels of acetylation of uronic acids produced by P. aeruginosa strains FRD1,
FRD1175, and JLP113. Data are shown as mean and standard deviation for three separate
experiments. While significantly decreased from the amount of acetyl groups per milligram of
uronic acids for alginate produced by strain FRD1, levels of alginate acetylation in strain JLP113
were significantly increased over background (FRD1175) (P < 0.001, as determined by Student’s
t-Test).
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Strep-II tagged AlgF was purified from P. aeruginosa by gravity-flow column
chromatography as outlined in the Materials and Methods section. Upon subjecting the eluted
protein to fractionation by SDS-PAGE under non-reducing conditions and without heating of the
sample, higher molecular weight species could be visualized by immunoblotting. These reactive
bands at approximately 50 kDa and 33 kDa were eliminated when the protein sample was
subjected to SDS-PAGE under reducing conditions and after boiling (Figure 29 A. and B.)
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Figure 29 A and B. Immunoblot of affinity purified AlgF subjected to SDS-PAGE under
reducing and non-reducing conditions. A. Immunoblot of affinity purified AlgF subjected to
SDS-PAGE under non-reducing conditions and without boiling shows higher molecular weight
complexes between 50 - 37 kDA and 37 – 25 kDa. B. Upon boiling and addition of a reducing
agent higher molecular weight complexes are disrupted. Western blots were screened with a
monoclonal α-Strep-tag II antibody and are representative of multiple experiments.
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In an attempt to determine the nature of these higher molecular weight complexes, the
purified AlgF protein was separated by 2-D Redox SDS-PAGE and silver stained (Figure 30).
The protein eluate was fractionated in the first dimension under non-reducing conditions and
without boiling, and then under reducing conditions in the second dimension. This format results
in individual proteins running on the diagonal, and proteins that possessed either intermolecular
or intramolecular disulfide bonds falling to either side of the diagonal. In the case of purified
AlgF subjected to 2-D Redox SDS-PAGE, a protein from the first dimension that possessed
intramolecular disulfide bonds can be seen to the left of the diagonal between approximately 15
and 20 kDa. The protein runs more slowly after disruption of the disulfide bond potentially due
to the loss of tertiary structure. The higher molecular weight complexes visible in the first
dimension are circled along with their potential corresponding proteins in the second dimension.
Proteins falling to this side of the diagonal represent proteins predicted to be involved in
intermolecular disulfide bonding. While complexed together in the first dimension, disruption of
disulfide bonds under reducing conditions allows proteins to run at their individual, lower
molecular weights. The complexes do not appear to be oligomers of AlgF as the proteins are
falling either above or below the molecular weight of AlgF in the second dimension. AlgF or
variants would fall along the horizontal line highlighted by the arrow. To confirm that the
proteins from the complexes were not AlgF, an identical 2-D Redox SDS-GEL was transferred
to PVDF and screened with α-Strep antibody. Only the AlgF protein spot indicated by the arrow
on the silver-stained gel was detected by the antibody, indicating that the other proteins were not
AlgF (data not shown).
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Figure 30. Affinity purified AlgF subjected to 2-D Redox SDS-PAGE. Silver-stained 2-D
Redox SDS-PAGE of affinity purified AlgF shows AlgF and co-purified proteins involved in
both intramolecular and intermolecular interactions.
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To identify the highlighted interacting proteins, protein spots were excised and subjected
to mass spectrometry analysis. To increase the protein available for analysis, multiple gels were
run and protein spots were pooled as outlined in the Materials and Methods section.
Unfortunately, mass spectrometry analysis did not yield any peptide sequences matching
Pseudomonas proteins. This was likely due to insufficient amounts of the interacting proteins.

Construction of AlgF site-directed mutant
As mass spectrometry analysis was unable to identify the interacting proteins visualized
by 2-D Redox SDS-PAGE of affinity purified AlgF, a strategy was devised to mutate the
cysteine residue in AlgF to a serine residue in the P. aeruginosa FRD1 genome. This would
allow for analysis of the alginate produced by the strain and a definitive determination as to the
importance of the cysteine residue to AlgF function. Serine was chosen for the substitution
because its basic structure is similar to that of cysteine but contains a hydroxyl in place of the
sulfhydryl. This change would abolish any possibility for intermolecular protein interactions
based on disulfide bonds, but would not be likely to result in drastic structural changes in the
protein.
As outlined in the Materials and Methods section, a non-replicative plasmid construct
that would result in the desired amino acid changes upon integration into the P. aeruginosa
FRD1 genome was successfully created. Repeated attempts to obtain products of even a single
crossover event, however, were not successful. Even attempted conjugation into the P.
aeruginosa PAO1 strain was unsuccessful, indicating that lack of sufficient homologous
sequence was not the likely source of difficulty. Efforts are ongoing to generate this mutant.
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Discussion
The approach of expressing and purifying affinity-tagged P. aeruginosa alginate
biosynthesis proteins from P. aeruginosa instead of E. coli was adopted in an effort to obtain the
most biologically relevant data possible regarding protein interactions. As there are currently no
assays available to validate the activity of purified alginate acetylation proteins, allowing for
protein processing and folding within the native environment would seem the mostly likely
avenue for isolating functioning protein. Co-purification experiments using this system would
also be simplified as any accessory proteins required for binding would be available.
While solid phase overlay and dot blot experiments using Strep-II tagged AlgF did not
result in the identification of any interacting proteins (data not shown), fractionation of purified
tagged protein under reducing and non-reducing conditions indicated that some interaction was
occurring. In some cases, higher molecular weight complexes were even visible under reducing
conditions as in Figure 25 in JLP113 at the 6 hour time point. In this case, it is possible that the
reducing capacity of the buffer was overwhelmed by the quantity of protein and was unable to
disrupt all complex formation. The results of the 2-D Redox SDS-PAGE experiments reinforced
what was seen in the first dimension by allowing visualization of the possible interacting
proteins. The inability to identify the individual proteins by mass spectrometry because of their
low abundance was an unfortunate result.
As a possible solution to the inability to get sufficient amounts of interacting proteins in
the second dimension for mass spectrometry analysis, the periplasmic fraction of P. aeruginosa
was isolated and screened with α-AlgF antibody. While AlgF was detected in the periplasmic
fraction, silver staining of an identical SDS-PAGE gel also detected numerous other proteins in
the fraction. Excision of an individual band on the SDS-PAGE gel corresponding to a reactive
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band on the immunoblot would not have been possible due to multiple bands of similar intensity
in the same area.
A surprising result in these studies was the low level of acetylation seen in the JLP113
strain (algF deletion strain complemented with Strep-II tagged AlgF). While acetylation was
clearly taking place, it occurred at a much lower level than the FRD1 strain. In the immunoblot
in Figure 26, it appears that the tagged AlgF is running at a higher molecular weight than the
wild-type. While the Strep-II tag adds 1 kilodalton, the difference in migration appears more
significant. This could indicate that a significant portion of the tagged protein is not folding
correctly or is perhaps retaining its signal sequence. This could account for the low
complementation seen in the JLP113 strain.
It is still likely, however, that the protein produced from this construct in P. aeruginosa
would produce more viable binding partners than a construct produced in E. coli where there
would be no way to determine any level of activity and folding and cleavage issues would likely
be increased.
A possible avenue to improve the complementation of a tagged AlgF construct might be
to engineer a construct which replaces the algF signal sequence with the algX signal sequence.
As a Strep-II tagged construct has been shown to fully complement an algX deletion strain,
indicating proper export to the periplasm and cleavage of the signal sequence, use of the algX
signal sequence may improve results [15].
Another possibility would be the use of a different affinity tag. While protein recovery of
a His-tagged AlgF construct was poor and complementation of acetylation was not to the levels
of the Strep-II AlgF construct (data not shown), there are other affinity tags available that could
be investigated.
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Conclusions
The goal of this work was to garner new and relevant information regarding the
mechanism of alginate acetylation in Pseudomonas aeruginosa. The lack of acetylation of the
small uronics produced by the alginate biosynthesis mutants in this study provides important data
about where within the cell alginate acetylation occurs. Since the data indicate that a uronic acid
polymer of some specific size is required for acetylation to occur, this supports a localization of
the acetylation process to the periplasm where polyuronic fragments would be present.
The site-directed mutation of a conserved histidine residue in AlgX did not result in
abolition of alginate acetylation as it did in the alginate acetylation protein AlgJ. While the
mutation allowed the role of AlgX in the purported periplasmic scaffold complex to be
maintained, the results of the uronic acid and acetylation assays suggested that algX is not
involved in acetylation. Future work regarding AlgX could include an additional mutation of a
neighboring histidine residue to ensure that it is not compensating for the original mutation, and
random mutagenesis of algX to look for interesting phenotypes.
AlgF-Strep-II tagged co-purification experiments and 2D-Redox SDS PAGE indicated
the presence of three proteins that may interact with the alginate acetylation protein AlgF via
disulfide bonding. While adequate amounts of protein could not be isolated for identification by
mass spectrometry, a site-directed mutation in the P. aeruginosa FRD1 chromosome of the lone
cysteine residue in AlgF to a serine residue is being pursued. This strategy will conclusively
determine the necessity of this residue for alginate acetylation.
Transcriptional analysis of the alginate biosynthesis operon conducted in this work
indicates the possibility for previously unknown regulation within the operon. The ability to
manipulate the level of alginate acetylation in P. aeruginosa strain FRD1 based on growth media
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was accomplished by growth in Modified Alginate Promoting media and by the addition of
MOPS to Luria-Bertani media. This finding led to further investigation into the possible
mechanism for this change. Beta-galactosidase assays conducted on lacZ fusions to regions
upstream of the algG and algI alginate biosynthesis genes resulted in the discovery of two
previously unidentified promoter regions. Examination of the nucleotide sequence in both of
these promoter regions showed significant homology to the -10 and -35 regions of the
Azotobacter vinelandii algR promoter. Quantitative real-time PCR experiments demonstrated
that transcript levels of the alginate biosynthesis genes are not consistent across the operon and
that additional regulation within the operon may be necessary to ensure adequate transcription of
all alginate biosynthesis genes. This additional regulation would also provide a method for
altering the acetylation and epimerization level of the alginate polymer as may be required by the
bacteria under differing environmental conditions. Future work regarding transcription of the
alginate biosynthesis operon could include: qRT-PCR on the remaining alginate biosynthesis
genes, analysis of possible transcriptional stop sites within the operon, and truncation of the algI
and algG upstream regions to determine areas required for promoter activity.
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